From: ITNDaily on behalf of Stephanie Sherman Subject: Mount Sinai In The News - July 29, 2016 Date: Friday, July 29, 2016 11:20:39 AM Attachments: ATT00002.txt

In the News July 29, 2016

WBUR News – July 28 Doctors Need A New Skill Set For This Opioid Abuse Treatment — Karen Shakerdge Braeburn Pharmaceuticals, the company behind the newly FDA-approved treatment Probuphine, is teaching doctors how to use it. Although addiction specialists welcome Probuphine, which delivers a constant dose of the drug buprenorphine over six months, at this early stage it's complicated for physicians to add it to their repertoire. Patients using Probuphine were 14 percent more likely to stay opioid-free compared to those using a daily sublingual version of buprenophine, according to a study published this month in JAMA, the Journal of the American Medical Association. So it's good to have another way to deliver medication-assisted treatment, says Richard Rosenthal, medical director of addiction psychiatry for the Mount Sinai Health System. Rosenthal was one of two principal investigators on a Probuphine clinical trial. "Everybody is waking up to the fact that we're in the midst of an opioid epidemic," says Rosenthal. "There are actually very few medications for addiction of any kind. Given the addiction treatment system in the United States, most of the treatment that's given is psychosocial. There's very little use of FDA-approved medications." - Richard N. Rosenthal. MD, Professor, Psychiatry, Mount Sinai West Learn more: http://www.wbur.org/npr/487080738/doctors-need-a-new-skill-set-for-this-opioid-abuse- treatment

MD Alert – July 28 Some Non-Celiac Gluten Sensitivity Patients May Have 'Celiac Lite' Disease — Marilynn Larkin A subset of patients with non-celiac gluten sensitivity (NCGS) may actually have a form of celiac disease, researchers in Spain report. A diagnosis of NCGS requires ruling out celiac disease on the basis of negative celiac serology and a duodenal biopsy of normal villi (no villous atrophy) in a person who is currently on a diet that contains gluten, but those diagnostic criteria may need to be revisited. Researchers conducted a small proof-of-concept study that aimed to demonstrate that gluten can trigger clinical symptoms in a subgroup of patients who currently fulfill the diagnostic criteria NCGS. Recent trials suggest that only a minority of those patients will exhibit symptoms in response to a gluten challenge. Commenting by email, Dr. Gina Sam, director of the Gastrointestinal Motility Center at The Mount Sinai Hospital in New York City said, "This study suggests that patients who do not have celiac disease but still have symptoms like a celiac patient (NCGS patients) do respond to a gluten-free diet. - Gina Sam, MD, MPH, Assistant Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Gastrointestinal Motility Center, The Mount Sinai Hospital Learn more: http://www.mdalert.com/news/article/some-non-celiac-gluten-sensitivity-patients-may- have-celiac-lite-disease#sthash.TsRYUq2o.dpuf

TDN – July 28 What Happens When You're Hypnotized? — Dennis Thompson Skeptics view hypnosis as a little-understood parlor trick, but a new study reveals real changes occur in the brain when a person enters a hypnotic state. Some parts of the brain relax during the trance while others become more active. Hypnosis was the first Western form of psychotherapy, but little is known about how it actually works. Experts selected 57 people for a study out of a pool of 545 potential participants. Thirty-six of the 57 displayed a high level of hypnotic susceptibility, while the other 21 did not appear to be very hypnotizable. Using MRI, researchers measured the subjects' brain activity by detecting changes in blood flow. This study provides "important evidence" that could help convince skeptical patients of hypnosis' potential benefits, said Guy Montgomery, PhD, associate professor of oncology, at the Icahn School of Medicine at Mount Sinai. However who specializes in integrative behavioral medicine. Montgomery added that it will take further research to make this specific knowledge directly useful in daily medicine. "How would I use this information to enhance procedures for patients?" he said. "I don't really know." - Guy H Montgomery, PhD, Oncology, Associate Professor, Director of the Integrative Behavioral Medicine Program, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital Learn more: http://tdn.com/lifestyles/health-med-fit/what-happens-when-you-re- hypnotized/article_2e3da5d0-e793-5673-af47-4a642618e466.html

The Guardian – July 28 Russian Olympic Team's Drug Usage Could Have Long Term Effects On Athletes' Health– Olga Oksman Further revelations in the Russian doping scandal have rocked the upcoming Olympic Games. Over 100 Russian athletes who would have competed in Rio have been barred due to an investigation into a state-run doping program that involved administering a cocktail of anabolic steroids to the country’s world-class athletes. Anabolic steroid use is nothing new when it comes to high-level athletes. The steroids found in Russia’s doping cocktail – nicknamed “The Duchess” by a Russian official – are often abused. Around 3%-5% of the population uses steroids, estimates Thomas Hildebrandt, assistant professor of psychiatry at the Icahn School of Medicine at Mount Sinai. While the muscle boosting effects of doping are well known, it is the mental effects, and what happens when someone finally stops using, that are often ignored. - Thomas Hildebrandt, PhD, Assistant Professor, Psychiatry, Icahn School of Medicine At Mount Sinai Learn more: https://www.theguardian.com/lifeandstyle/2016/jul/28/russian-olympic-rio-team-drug- steroids-health-effects

Style Caster – July 28 Does Cold Water Actually ‘Shut’ Your Pores? — Lauren Caruso We’ve all been told approximately one million times that hot water opens your pores, and cold water, by the law of duality, shuts them. Bad news, though: We’ve been lied to—sort of. While pores aren’t exactly muscles themselves, “There are many tiny muscles in the skin attached to the hair follicles,” says Ellen Marmur, an associate clinical professor of dermatology, genetics, and genomic research at Icahn School of Medicine at Mount Sinai. “These piloerector muscles contract when cold— think goose bumps. Plus, all of the superficial muscles of the face are attached to the skin.” Plus, “Unless you’re following with moisturizer right away, splashing your face with any water will lead to evaporation and dryness of the outer layer of skin,” adds Heidi Waldorf, director of laser and cosmetic dermatology at The Mount Sinai Hospital. Looking for something more intense and long-lasting? If you’ve already walked down the road of chemical peels with little reward, both derms suggest Clear + Brilliant, an in-office laser treatment that uses similar wavelengths to Fraxel laser resurfacing but at lower energies, Dr. Waldorf says. And for now, don’t worry about ending your nightly face wash with a splash of cold water to the face—unless, of course, you’re just trying to keep yourself awake. - Heidi A Waldorf, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director Of Laser And Cosmetic Dermatology, The Mount Sinai Hospita, - Ellen S Marmur, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai Learn more: http://stylecaster.com/beauty/does-cold-water-shut-pores/#ixzz4Fo4kznB5

Health Day – July 29 Is Non-Celiac Gluten Sensitivity Real? — Dennis Thompson Gluten sensitivity appears to be a real medical problem, and not a figment of the popular imagination conjured up by the gluten-free craze, a new study contends. Some people suffer changes within their bodies after eating gluten that are separate and distinct from those that accompany either celiac disease or wheat allergy, researchers report. Dr. Christina Tennyson is a gastroenterologist with The Mount Sinai Hospital. She called the new research "an exciting study as it will help further research of patients with non-celiac wheat sensitivity.” “This study demonstrates that there are objective markers of inflammation and cell damage seen in individuals with non-celiac wheat sensitivity. These mechanisms appear different than celiac disease," Tennyson added. "There have been no biomarkers available to diagnose non-celiac gluten sensitivity and this has made it difficult for doctors to accurately diagnose and monitor patients that report non-celiac gluten sensitivity," she said. - Christina Tennyson, MD, Assistant Professor, Gastroenterology, Icahn School of Medicine at Mount Sinai Learn more: https://consumer.healthday.com/vitamins-and-nutrition-information-27/gluten-975/is-non- celiac-gluten-sensitivity-real-713362.html

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

This message and any attachments are confidential and intended solely for the use of the individual or entity to which they are addressed. If you are not the intended recipient, you are prohibited from printing, copying, forwarding, saving, or otherwise using or relying upon them in any manner. Please notify the sender immediately if you have received this message by mistake and delete it from your system. From: ITNDaily on behalf of Kozar, Matt Subject: Mount Sinai In The News - July 28, 2016 Date: Thursday, July 28, 2016 1:25:51 PM Attachments: ATT00003.txt

In the News July 28, 2016

National Pain Report – July 28 Buprenorphine Implant May Help Opioid-Dependent People Better Adhere to Treatment A study published in JAMA by researchers from the Icahn School of Medicine at Mount Sinai investigated subdermal (under the skin) buprenorphine implants and their effect on opioid-dependent patients. They found that after six months patients’ maintained very low or no illicit use of opioids relative to daily sublingual (under the tongue) buprenorphine maintenance treatment. “Buprenorphine is an effective treatment for opioid dependence; however, adherence to daily dosing for management of chronic disorders is challenging. An implantable buprenorphine delivery system reduces adherence issues and may improve efficacy,” the authors write. - Icahn School of Medicine at Mount Sinai Learn more: http://nationalpainreport.com/buprenorphine-implant-may-help-opioid-dependent- people-better-adhere-to-treatment-8831036.html

Crain’s Health Pulse – July 27 Oscar to raise prices, cut network in half next year Health insurer Oscar will cut its network in half for 2017 and will no longer cover many of New York City’s largest health care providers, the company announced in a blog post on its website Tuesday. The move signals a shift in corporate strategy to focus on just a few large health systems, after initially using MagnaCare’s network and offering its customers a broad array of hospitals and doctors. Niyum Gandhi, Mount Sinai’s chief population health officer, said he believes consumers will be getting greater value in exchange for less choice. Mount Sinai, which will be Oscar’s lone in-network health system in Manhattan, has been working closely with the insurer for about a year on projects that will make appointment scheduling and billing easier for patients. “There are areas where we can make our industry’s back-end garbage not the consumers’ front-end problem,” he said. - Niyum Gandhi, Chief Population Health Officer, Mount Sinai Health System Learn more: http://patch.com/new-york/upper-west-side-nyc/plans-filed-convert-former-st-lukes- hospital-buildings-apartments

CBS Evening News – July 27 Supplements Meant To Help Couple Get Pregnant Land Husband In Hospital — CBS Forty-three-year-old tattoo artist Bobby Cimorelli and his wife Margaret have struggled to get pregnant. Cimorelli decided to try over-the-counter testosterone supplements. "I was really bloated, my blood pressure was really high," Cimorelli said. Within weeks, he wound up in the emergency room. Doctors said the supplements were the likely culprit. Dr. Aida Vega, an internist and director of Primary Care Associates at Mount Sinai The Mount Sinai Hospital, explained that doctors and patients often don't discuss supplements, which can lead to problems. It is important for physicians to understand why their patient is taking or wants to take a supplement, Dr. Vega said. "If you understand why they're taking it, you can steer them in the proper direction." - Aida Vega, MD, Assistant Professor, Internal Medicine, General Medicine, Icahn School of Medicine at Mount Sinai, Director of Primary Care Associates at Mount Sinai Learn more: http://www.cbsnews.com/news/supplements-meant-to-help-couple-get-pregnant-land- husband-in-hospital/

Yahoo – July 27 Former Tennis Star Chris Evert Says We Don’t Talk Enough About the Difficulties of Menopause — Jenna Birch Evert says she struggled with the hormonal changes just after she entered midlife. “I don’t know, I was going through menopausal stuff that doesn’t get talked about enough — what women go through, you know, at 50-ish” she explained. So, for those of us who haven’t experienced it, how tough can menopause be? Mamta Mamik, MD, an assistant professor of obstetrics, gynecology, and reproductive science at the Icahn School of Medicine at Mount Sinai, says the transition can carry some difficult side effects. Fortunately, Mamik says there are plenty of options for women who are enduring uncomfortable side effects of menopause. “Using soy products alleviates some of the symptoms,” she suggests. “Herbal remedies like black cohosh help as well, in addition to a low-dose selective serotonin reuptake inhibitor (SSRI) to help alleviate hot flashes.” If these remedies don’t help or if menopause symptoms are more severe, you can discuss the pros and cons of hormone replacement therapy with your ob-gyn. And lastly, take heart: “Symptoms usually resolve within a year or two,” Mamik says. - Mamta M Mamik, MD, Assistant Professor, OBGYN, Urogynecology, Icahn School of Medicine at Mount Sinai Learn more: https://www.yahoo.com/beauty/former-tennis-star-chris-evert-says-we-dont-talk- 232549219.html

Tech Insider – July 27 Fighter Pilots Invented A Revolutionary Way For Surgeons To Peer Inside People's Skulls — Chris Weller Surgical Theater, an Ohio-based company that brings state-of-the-art virtual reality to brain surgeons was founded by Alon Geri and Moty Avisar, veterans of the Israeli Air Force. Physicians in thick black goggles can step inside a patient's skull, explore the malformed region, craft a strategy for entry, elimination, and exit, and even do dry runs of the surgery itself. When it comes time to make the first incision, there are fewer surprises. The technology, which Surgical Theater calls SNAP (Surgical Navigation Advanced Platform) uses existing MRI scans to create 3D models, which are compatible with virtual reality. Geri and Avisar, both engineers, developed SNAP after working extensively on flight simulation. They realized in the early 2000s that the problems facing brain surgeons were nearly identical to those of their fellow pilots. "You do it wrong the first time, and it's either game over or you spend the rest of the surgery putting out fires," Geri tells Tech Insider. With SNAP, doctors can put the VR goggles on their patients so they can see their own brains before they go under. The surgeries are also more successful. Patients recover faster since SNAP allows doctors to avoid making any unnecessary incisions. SNAP is being used in nine locations so far, including Stanford, UCLA, and The Mount Sinai Hospital. Virtual reality is poised to become a mainstay in the operating room. - The Mount Sinai Hospital Learn more: http://www.techinsider.io/virtual-reality-brain-surgery-2016-7

WCBS – July 27 Investigators: Heroin, Fentanyl Sting Leads To 24 Arrests On Long Island Prosecutors announced Wednesday that two dozen people were arrested, and nearly 4 kilograms of heroin and fentanyl were seized, in a 10-day drug sting on Long Island. Fentanyl is so dangerous that DEA agents have been instructed not to perform tests to identify the drug in the field. Two officers in Atlantic County, New Jersey accidentally inhaled fentanyl while bagging it during a bust. Dr. Michael Fiori, associate professor of psychiatry at Icahn School of Medicine at Mount Sinai, said the officers’ reaction to the drug is even quicker than what a frequent drug user would experience. “Their body’s not tolerant to it, so they rapidly can develop respiratory depression, low blood pressure, and to them it feels like the light is going out,” Fiori said. - Michael Fiori, MD, Director of Addictions, Mount Sinai Beth Israel, Associate Professor of Psychiatry, Icahn School of Medicine at Mount Sinai Learn more: http://newyork.cbslocal.com/2016/07/27/long-island-heroin-fentanyl-arrests/

Self – July 27 Here Are All The Foods That Can Help You Debloat– Audrey Bruno Bloating is uncomfortable. It’s also complicated, because there’s no one thing that causes it. What we commonly know as bloating may also be your body retaining water, which David Greenwald, MD, director of clinical gastroenterology and endoscopy at The Mount Sinai Hospital, says can often be a side effect of a high-sodium diet. Before you look for a cure to your bloat, Greenwald says it’s important to understand what’s causing it. This will enable you to choose the right solution and alleviate that unwanted swell as quickly as possible. - David Greenwald, MD, Senior Faculty, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Clinical Gastroenterology, Endoscopy, The Mount Sinai Hospital Learn more: http://www.self.com/food/2016/07/here-are-all-the-foods-that-can-help-you-debloat/

NY Magazine – July 27 Is There Natural Sunscreen in Carrots? — Susan Rinkunas While slathering yourself in carrot cake will not provide UV protection, certain botanicals may offer some protection against ultraviolet light, but this doesn’t mean you should go buy a bunch of ingredients and play chemist, says Joshua Zeichner, MD, the director of cosmetic and clinical research in dermatology at The Mount Sinai Hospital. Although some studies claim that raspberry seed oil or essential oils absorb some UV light, they were conducted in petri dishes using light meters — a far cry from the tests that sunscreen manufacturers must conduct to prove the SPF claims on their labels. “In theory or in the lab, an oil may give some protection, but in the real world, you’re applying it to the skin with other ingredients and you’re sweating and it’s exposed to UV light — the conditions are very different,” says Dr. Zeichner. -Joshua Zeichner, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai Learn more: http://nymag.com/thecut/swellness/2016/07/is-there-natural-sunscreen-in-carrot-oil.html

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Slotnick, David To: [email protected] Subject: Mount Sinai In The News - July 27, 2016 Date: Wednesday, July 27, 2016 11:11:04 AM Attachments: ATT00002.txt

In the News July 27, 2016

ABC7NY – July 26 New Obesity Treatment Targeting Hunger Hormone Showing Promise — Shirleen Allicot There's a new treatment with no major surgery that targets the hunger hormone and it's getting promising results. Doctors at The Mount Sinai Hospital, in partnership with Johns Hopkins, are studying ways to interrupt the so-called "hunger hormone." One of the things we have learned is that there is a hormone named ghrelin," Dr. Aaron Fischman said. "Ghrelin is produced in the stomach, and so we think if we can reduce this level, we can reduce a patient's hunger." Unlike traditional weight loss surgeries, this trial involves surgery that is minimally invasive. "We use a very small catheter, and we insert it into the patient's wrist, almost like an IV," Dr. Fischma said. "Once the catheter is placed in the arm, we direct a very small catheter into the artery that feeds the stomach." There have been 15 patients to undergo the surgery, and all of them have seen significant weight loss with no major complications. While the results are promising, the "beat obesity" surgery isn't yet approved by the FDA, so it isn't covered by insurance. - Aaron Fischman, MD, Assistant Professor, Radiology Icahn School of Medicine at Mount Sinai Learn more: http://abc7ny.com/health/obesity-treatment-targeting-hunger-hormone-showing-promise/1443824/

CNN – July 26 Does It Pass The 'Smell Test'? Seeking Ways To Diagnose Alzheimer's Early — Susan Scutti Alzheimer's researchers are looking to our noses and our eyes for early signs of disease. Researchers discovered that signs of plaque in either the brain scan or spinal fluid predicted decline while smell test scores did not. Still, participants with an UPSIT score of less than 35 were three times more likely to decline than those with a score greater than 35. According to Samuel Gandy, MD, Professor of Neurology and Psychiatry at the Icahn School of Medicine at Mount Sinai Hospital, "Reports like these appear every few months, but none have held up to careful scrutiny." Unfortunately, the findings are never "robust or reproducible," said Gandy, who is not affiliated with any of these studies. - Samuel Gandy, MD, PhD, Professor, Neurology, Psychiatry, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Center for Cognitive Health Learn more: http://www.cnn.com/2016/07/26/health/alzheimers-eye-and-smell/index.html

Radiology Business – July 25 Do Male Patients Diagnosed With Gynecomastia Need Mammography? — Michael Walter Gynecomastia is the most common diagnosis for male patients experiencing breast enlargement. It is also benign, though it can result in pain. According to a study published by the American Journal Roentgenology, when a patient is diagnosed with gynecomastia, further imaging tests such as mammography and ultrasound are not necessary if the patient has undergone chest CT within eight months. Overall, the data revealed “a high level of concordance in morphologic features and distribution of gynecomastia” between the mammogram and the CT. In just one of the 62 cases, gynecomastia was evident in the mammogram and not the recent CT; this was due to cachexia. Emily B. Sonnenblick, MD, Assistant Professor, Radiology at Icahn School of Medicine at Mount Sinai, and colleagues, studied data from 62 men who were diagnosed with gynecomastia after a mammogram and had also undergone CT within the last eight months. This was a retrospective study, and each diagnosis was made between January 2007 and June 2015.X -Emily B. Sonnenblick, MD, Assistant Professor, Radiology Icahn School of Medicine at Mount Sinai Learn more: http://www.radiologybusiness.com/topics/care-delivery/do-male-patients-diagnosed-gynecomastia-need-mammography

RDmag – July 26 Sub-set of Stem Cells Minimizes Risks When Used to Treat Damaged Hearts — PLOS Scientists use mathematical modeling to simulate human mesenchymal stem cell delivery to a damaged heart and found that using one sub-set of these stem cells minimizes the risks associated with this therapy. Researchers, led by Joshua Mayourian, student at the Icahn School of Medicine at Mount Sinai, simulated electrical interactions between these stem cells and heart cells to develop insight into possible adverse effects, as well as to hypothesize new methods for reducing some potential risks of this therapy. Their computer simulations demonstrate that one family of human mesenchymal stem cells minimizes disturbances in cardiac single-cell and tissue level electrical activity. By identifying the benefits of using this specific sub-set of human mesenchymal stem cells this research may enhance safety for heart attack patients receiving stem cell therapy. This advance could therefore lead to new clinical trials and future improvements in treatment of patients with heart failure. - Joshua Mayouria, 2nd Year MD/PhD Student, Icahn School of Medicine at Mount Sinai Learn more: http://www.rdmag.com/news/2016/07/sub-set-stem-cells-minimizes-risks-when-used-treat-damaged-hearts

SELF Magazine – July 27 Some hair just wasn't meant to be groomed – Amy Marturana Shaving, waxing, and lasering off body hair has become so commonplace that many women don’t even think twice about it. You’re probably in one of two camps: to remove or not to remove. But if you’re in the former, you should know that your gynecologist may be a little concerned about your penchant for going bare down there. We have pubic hair for a pretty legit reason: to protect your privates. “It provides a cushion against friction that may cause skin injury, prevents dirt and bacteria from entering the vagina, and can help to spread pheromones [the chemicals we excrete to entice potential partners] and reduce heat loss,” Mamta Mamik, MD, associate professor of obstetrics, gynecology, and reproductive science at the Icahn School of Medicine at Mount Sinai, tells SELF. - Mamta Mamik, MD, Assistant Professor, Obstetrics, Gynecology, Reproductive Science, Icahn School of Medicine at Mount Sinai Learn more: http://www.self.com/wellness/2016/07/6-reasons-your-gyno-wishes-youd-leave-your-pubic-hair-the-f-alone/

Everyday Health – July 27 Type 2 Diabetes and Summer: Tips to Beat the Heat – Beth Orenstein When you have type 2 diabetes, your diabetes management is a year-round commitment. But during the summer, your diabetes may require even more diligence. Extreme heat and humidity can affect your blood sugar, your medication and supplies, and your overall health. Extreme heat is a stress on the body, and any stress can release hormones that will raise blood sugar levels, says Deena Adimoolam, MD, assistant professor of medicine, endocrinology, diabetes, and bone disease at the Icahn School of Medicine at Mount Sinai. - Deena Adimoolam, MD, Assistant Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai Learn more: http://www.everydayhealth.com/hs/type-2-diabetes-guide-healthy-habits/diabetes-summer-beat-heat/

Philly – July 27 Philly rower puts off med school, is off to Olympics — Natalie Pompilio A few years ago, Mount St. Joseph Academy graduate and dual citizen of the US and Nigeria, Chierika Ukogu, contacted the Nigerian Olympic Committee, asking to represent the country in Rio in 2016 in a rowing event. In October, she proved herself an Olympian, winning a place in Brazil with a third-place finish in the FISA African Qualification Regatta, unexpectedly, for the first time putting a Nigerian rower over a well-respected Egyptian rower. To pursue this dream, Ukogu put medical school on hold for two years. If all goes as planned, she will race Saturday in the women's single scull event in Rio and then, two days later, fly to New York to begin classes at the Icahn School of Medicine at Mount Sinai. -Icahn School of Medicine at Mount Sinai Learn more: http://www.philly.com/philly/sports/20160727_Philadelphia_rower_postponed_medical_school_to_represent_Nigeria_in_Rio_Olympics.htm

Broadway World – July 27 Haile King Rubie: Speaking Colors Exhibition to Open New Gallery in Harlem — BWW News Desk An exhibition of works by Haile King Rubie, a 26-year-old Harlem artist with Down Syndrome, will inaugurate the Clara Francis Gallery, a new Harlem art spot, July 27 to August 17, 2016. The exhibition, "Haile King Rubie: Speaking Colors," is primarily drawn from Rubie's "art waves" of 2013 and 2015 and features contemplations of his otherwise inaccessible inner world. Haile has donated two paintings to the The Mount Sinai Hospital Pediatric Heart Center following the heart-reconstruction surgery that saved his life in 2008. The new gallery space, located at 2070 Adam Clayton Powell Jr. Blvd., is a welcome addition to Harlem's art district. - Mount Sinai Health System Learn more: http://www.broadwayworld.com/article/HAILE-KING-RUBIE-SPEAKING-COLORS-Exhibition-to-Open-New-Gallery-in- Harlem-20160726

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Stephanie Sherman Subject: In The News - July 26, 2016 Date: Tuesday, July 26, 2016 1:53:01 PM Attachments: ATT00002.txt

In the News July 26, 2016

Politico New York – July 25 Good Genes — Dan Goldberg Researchers at the Icahn School of Medicine at Mount Sinai identified a panel of genes that can help predict whether a transplanted kidney will later develop fibrosis, according to an article in the Lancet. - Icahn School of Medicine at Mount Sinai Learn more: No web link available

Spine Universe – July 25 Clostridium Difficile Infection Is Rare But Costly/Deadly Complication In Cervical Spine Surgery: Commentary by lead author Sheeraz A. Qureshi, MD, Associate Professor, Orthopaedics, Icahn School of Medicine at Mount Sinai — Kristin Della Volpe Clostridium difficile infection occurs in approximately 0.08% of patients following postoperative cervical spine surgery and is associated with an increased risk of in-hospital mortality and costs of more than $6.5 million per year, according to data from a retrospective database analysis. The study findings suggest that "C. difficile is something that spine surgeons need to consider when managing their patients, especially in the postoperative period. “Surgeons best avoid C. difficile infection in these patients by following guidelines for antibiotic usage,” said senior author Sheeraz A. Qureshi, MD, Associate Professor of Spinal Surgery at Mount Sinai - Sheeraz A, Qureshi, MD, Associate Professor, Orthopaedics, Icahn School of Medicine at Mount Sinai Learn more: http://www.spineuniverse.com/professional/news/clostridium-difficile-infection-rare- costlydeadly-complication-cervical-spine

Healio’s HemOnc Today – June 13 LEADER Trial: Victoza Lowers Risk For CV Death, MI, Stroke In High-Risk Type 2 Diabetes Patients with type 2 diabetes and a history of cardiovascular disease assigned Victoza therapy saw reduced risk for cardiovascular death, nonfatal myocardial infarction and stroke vs. those assigned a placebo, according to an analysis of the LEADER trial results presented at the American Diabetes Association Scientific Sessions. Derek LeRoith, MD, Professor of Endocrinology offered his perspective as “The LEADER trial demonstrated an effect of a GLP-1 agonist on improvement in cardiovascular disease in type 2 diabetic patients. In contrast to a number of recent diabetic outcome trials that failed to demonstrate improvements in CV disease, we now have two trials that show improvement. These two trials — the EMPA-REG and the LEADER trial — give us confidence that improving HBA1c and glucose control in type 2 diabetes, over the already established effects of cholesterol and blood pressure control, will further prevent CV disease in our patients” - Derek LeRoith, MD, Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, Chief, Division of Endocrinology, Diabetes and Bone Disease, The Mount Sinai Hospital Learn more: http://www.healio.com/endocrinology/diabetes/news/online/%7Bacf18254-7d28-4fd3-a070- 796d368e335e%7D/leader-trial-victoza-lowers-risk-for-cv-death-mi-stroke-in-high-risk-type-2-diabe

Healio’s HemOnc Today – July 25 Structured, Coordinated Approach Needed For Pediatric Diabetes Patients Transitioning To Adult Care Approximately 1.25 million U.S. children have type 1 diabetes, and more than 18,000 youths are diagnosed each year, according to the CDC. That number is only expected to grow in coming years: Data from the ongoing SEARCH for Diabetes in Youth study revealed that the incidence of type 1 diabetes in youths increased 21% between 2001 and 2009. “It’s a wide range,” Carol Levy, MD, Associate Professor of Endocrinology, Diabetes and Bone Disease of the Icahn School of Medicine of Mount Sinai, told Endocrine Today. “Some kids will be very responsible and will be handling disease management themselves already by the time they come to you. Other patients, mom and dad will be doing everything. We have to work with them to explain, ‘Hey, the ball’s in your court’.” -Carol J Levy , M.D. , Associate Professor, Endocrinology, Diabetes and Bone Disease, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine of Mount Sinai Learn more: http://www.healio.com/endocrinology/pediatric-endocrinology/news/print/endocrine- today/%7B6aae0510-1141-419c-b148-bcb43b26667f%7D/structured-coordinated-approach-needed-for- pediatric-diabetes-patients-transitioning-to-adult-care

City Limits – July 26 When New Moms Get Sick, Race—And Hospitals—Matter — Bob Kirsch A new study confirms not only the importance of hospital quality to mothers' health but also the disparities New Yorkers encounter in accessing the best care. It finds that if self-identified black moms delivered at the same hospitals as self-identified white moms, nearly 1,000 black mothers in New York City could avoid every year a severe illness during their childbirth hospital stay. "Our data suggest that many black women are going to the worst performing hospitals in New York City," says Elizabeth Howell, MD, Vice Chair of research in the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai and lead author of the 2016 study, which looked at 353,773 deliveries in 40 New York hospitals from 2011 through 2013. "We have to improve these hospitals Sinai -Elizabeth Howell, Vice Chair of Research in the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai Learn more: http://citylimits.org/2016/07/26/when-new-moms-get-sick-race-and-hospitals-matter/

WTVR-CBS 6 News, Richmond-Petersburg, VA – July 23 How Safe Is The Synthetic Turf Your Child Is Playing On? — Lane Casadonte Synthetic turf can now be found at schools and sports parks across Virginia and the country. Supporters insist the fields are safe, cost effective, and environmentally friendly, but others point to dangerous side effects. Philip Landrigan, MD, the Dean for Global Health at the Icahn School of Medicine at Mount Sinai said, “parents should not forbid their kids from playing on these fields, but recommended be sure to have the child shower off very completely at the end of each time they play on the field." - Philip Landrigan, MD, MSc, Professor, Preventive Medicine, Pediatrics, Dean for Global Health, Icahn School of Medicine at Mount Sinai Learn more: http://wtvr.com/2016/07/23/how-safe-is-the-synthetic-turf-your-child-is-playing-on/

Every Day Health – July 25 Understanding The Stages Of Ulcerative Colitis: Personal Stories – Erica Patino Mild ulcerative colitis can be the most difficult form of the illness to diagnose. Lower levels of disease activity, or inflammation, may produce symptoms that are similar to those of other digestive disorders or that go unreported. “In mild cases, crampy abdominal pain is less severe and doesn’t limit day-to-day activities,” says David Greenwald, MD, Director of Clinical Gastroenterology and Endoscopy at Mount Sinai Hospital in New York City. “Mild colitis is not comfortable, but most people are able to continue what they usually do. However, they know something is wrong because of the hallmark symptom of bloody diarrhea.” - David Greenwald, MD, Senior Faculty, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Clinical Gastroenterology, Endoscopy, The Mount Sinai Hospital Learn more: http://www.everydayhealth.com/solutions/ulcerative-colitis-stages-stories-breakdown/#/mild

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

This message and any attachments are confidential and intended solely for the use of the individual or entity to which they are addressed. If you are not the intended recipient, you are prohibited from printing, copying, forwarding, saving, or otherwise using or relying upon them in any manner. Please notify the sender immediately if you have received this message by mistake and delete it from your system. From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 25, 2016 Date: Monday, July 25, 2016 12:05:02 PM Attachments: ATT00002.txt

In the News July 25, 2016

Clinical Psychiatry News – July 20 Buprenorphine implants rival daily sublingual buprenorphine for opioid dependence — Deepak Chitnis Using an implant device to administer buprenorphine for adult patients being treated for opioid addiction is a viable alternative to the standard sublingual buprenorphine, a recently published randomized clinical trial published suggests. “An implantable buprenorphine delivery system reduces adherence issues and may improve efficacy,” wrote Richard Rosenthal, MD, medical director of Addiction Psychiatry for the Mount Sinai Behavioral Health System, and his coinvestigators. Furthermore, buprenorphine implants may reduce the need for sublingual buprenorphine, decreasing its availability for diversion, misuse, and harms.” - Richard Rosenthal, MD, Professor, Psychiatry, Icahn School of Medicine at Mount Sinai, Medical Director, Addition Psychiatry, Mount Sinai Behavioral Health System Learn more: http://www.clinicalpsychiatrynews.com/specialty-focus/addiction-medicine/single-article-page/buprenorphine-implants-rival-daily-sublingual-buprenorphine- for-opioid-dependence/6aa5f9a042dea1c91b67409405d586de.html? oc_slh=&utm_source=News_CPN_eNL_072516&utm_medium=email&utm_content=Opioid%20dependence:%20Buprenorphine%20implants%20rival%20sublingual%20treatment Additional Coverage: Medpage Today: http://www.medpagetoday.com/psychiatry/addictions/59189 Medscape: http://www.medscape.com/viewarticle/866336

Deccan Herald – July 25 New Way to Predict, Prevent Damage In Donated Kidneys Scientists have identified a panel of genes which can help predict whether a transplanted kidney will later develop fibrosis, an injury which can cause the organ to fail. "This is the first finding of its kind," said Barbara Murphy, MD, a professor of nephrology at the Icahn School of Medicine at Mount Sinai, and the lead investigator on the study. "By helping us better understand the causes of damage to transplanted kidneys, this study has the potential to change how we monitor and manage all renal transplant patients.” - Barbara Murphy, MD, Professor, Medicine, Nephrology, Dean for Clinical Integration and Population Health, Icahn School of Medicine, System Chair, Department of Medicine, Mount Sinai Health System Learn more: http://www.deccanherald.com/content/559891/way-predict-prevent-damage-donated.html

Fierce Biotech – July 19 FDA Panel Gives Cautious Nod To Valeant Psoriasis Drug — Stacey Lawrence An FDA advisory committee recommended that the agency approve Valeant’s brodalumab to treat moderate-to-severe plaque psoriasis. But it also advised that the biopharma implement additional risk-management options for suicidal ideation--which had proved to be a problem in Phase III testing. "Brodalumab is an extraordinary drug that has meaningfully improved the quality of life of some of my most difficult-to-treat psoriasis patients, many of whom achieved complete skin clearance with this treatment," said Mark Lebwohl, MD, chairman of the department of dermatology at the Icahn School of Medicine at Mount Sinai. He was a lead investigator in Phase III testing. - Mark Lebwohl, MD, Professor, Chair, Dermatology, Icahn School of Medicine at Mount Sinai, System Chair, Dermatology, Mount Sinai Health System Learn more: http://www.fiercebiotech.com/biotech/fda-panel-gives-cautious-nod-to-valeant-psoriasis-drug-despite-suicide-concerns

New York Daily News – July 25 Relax, Moms — IVF Does Not Increase Risk of Breast Cancer — Nicole Lyn Pesce Many women have worried that pumping themselves with extra hormones before IVF treatments to stimulate their ovaries has put them at risk for breast cancer. But a new study of more than 25,000 women in the Netherlands published in JAMA revealed that the moms-to-be who underwent IVF were no more likely to get breast cancer after 21 years than both the general population and women treated for infertility who didn’t do IVF at the same time. “I think this is fantastic news. A lot of patients don't even attempt IVF, patients that would really be benefitted, because of some unfounded fears,” said Alan Copperman, MD, division director of reproductive endocrinology at the Icahn School of Medicine at Mount Sinai. - Alan Copperman, MD, Clinical Professor, Obstetrics, Gynecology, Reproductive Science, Division Director, Reproductive Endocrinology, Icahn School of Medicine at Mount Sinai Learn more: http://www.nydailynews.com/life-style/health/relax-moms-ivf-doesn-increase-risk-breast-cancer-article-1.2721953

New York Daily News – July 25 Zika Risk Is ‘Low’ In NYC — But Take These Precautions, Doc Says — Daniel Caplivski, MD Athletes like golfers Rory McIlroy and Jason Day have decided to forgo the 2016 Olympics in Rio because the mosquito-borne Zika virus is endemic there. But what about the New York metropolitan region — should New Yorkers and visitors be worried about catching the disease here? At this point, the risk appears very low, writes Daniel Caplivski, MD, director of the Travel Medicine Program at The Mount Sinai Hospital. Only a small number of cases of Zika have been reported in the United States, mostly among travelers who have visited parts of South America and the Caribbean, where the virus is common. - Daniel Caplivski, MD, Associate Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai, Director, Travel Medicine Program, The Mount Sinai Hospital Learn more: http://www.nydailynews.com/life-style/zika-risk-nyc-precautions-doc-article-1.2724399

General Surgery News – July 21 Column to Focus on New Medical Technologies — Victoria Stern Surgeons are bombarded with thousands of new medical technology innovations each year. Given the sheer volume of devices, “it is very difficult for new surgeons to tease out the good from the fad,” said Patricia Sylla, MD, an associate professor of surgery at the Icahn School of Medicine at Mount Sinai. Even more seasoned surgeons have a hard time.” - Patricia Sylla, MD, an Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai Learn more: http://www.generalsurgerynews.com/Technology/Article/07-16/Column-To-Focus-on-New-Medical-Technologies/37044

Well and Good – July 23 Is Sunscreen Messing With Your Fertility And Endocrine System? — Rachel Lapidos We’ve all been told time and time again to wear sunscreen—even when it’s not glaringly sunny. But about half of SPFs don’t live up to their claims, and now a very serious concern has been discovered by researchers at the University of Copenhagen: commonly used sunscreen filters could be lowering men’s fertility. We spoke with Alan Copperman, MD, division director of reproductive endocrinology at the Icahn School of Medicine at Mount Sinai, to understand just how concerned we should be when slathering on sun protection—and which sunscreens are safe. - Alan Copperman, MD, Clinical Professor, Obstetrics, Gynecology, Reproductive Science, Division Director, Reproductive Endocrinology, Icahn School of Medicine at Mount Sinai Learn more: http://www.wellandgood.com/good-advice/sunscreen-affect-on-fertility-sperm-endocrine-system/

Telemundo – July 20 Healthy Snacks: 14 Ideas With Less Than 100 Calories To Try This Summer Finding a healthy snack can be difficult. For a snack under 100 calories, Maria Elena Rodriguez, RD, CDN, program manager of Mount Sinai Health System’s Diabetes Alliance, suggests carrots and two tablespoons of chickpea paste. - Maria Elena Rodriguez, RD, CDN, CDE, Program Manager, The Diabetes Alliance at Mount Sinai Health System Learn more: http://www.telemundo.com/el-poder-en-ti/2016/07/11/snacks-saludables-14-ideas-con-menos-de-100-calorias-para-probar-este?cid=linkcommunity

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 22, 2016 Date: Friday, July 22, 2016 12:27:38 PM Attachments: ATT00002.txt

In the News July 22, 2016

Forbes – July 21 Where Is The Line Between What Is Ethical And Legal? — Raquel Baldelomar Just because a business practice is legal doesn’t mean it’s ethical. This is especially true in healthcare and pharmaceuticals. Kenneth L. Davis, MD, President and CEO of the Mount Sinai Health System, says the issue of drug prices boils down to a values issue of management that has to weigh the widespread availability and profitability of a drug. “I am well aware of how much drug companies have to spend on failed drugs before they have one that is a success. I am more than willing to say that that has to be accounted for when one contemplates a fair return on investment,” he says. “But that fair return on investment has to keep in mind that we are still in a business of healthcare and curing disease, which can’t be restricted to only some people who can afford it. There is a social responsibility there too.” - Kenneth L. Davis, MD, President, Chief Executive Officer, Mount Sinai Health System Learn more: http://www.forbes.com/sites/raquelbaldelomar/2016/07/21/where-is-the-line-between- what-is-ethical-and-legal/#c908b9415d5c

Medscape – July 21 Individualized, Ultrabrief ECT Effective for Geriatric MDD — Liam Davenport An individualized, ongoing electroconvulsive therapy (ECT) program, in combination with antidepressants, achieves sustained remission and prevents relapse in older patients with severe depression, new results from a two-phase study indicate. Charles Kellner, MD, director of ECT services at The Mount Sinai Hospital, and colleagues initially administered right unilateral ultrabrief pulse ECT, which is designed to minimize cognitive effects, plus medication to patients aged 60 years and older who had severe depression. "The newer right unilateral ultrabrief pulse ECT technique allows practitioners to be more liberal in prescribing additional ECT when needed," they wrote. - Charles Kellner, MD, Professor, Psychiatry, Director, Geriatric Psychiatry, Icahn School of Medicine at Mount Sinai, Director, ECT Service, The Mount Sinai Hospital Learn more: http://www.medscape.com/viewarticle/866447

PIX 11 – July 21 New Implant to Aid Patients in Battle Against Opioid and Prescription Painkiller Addiction — Ayana Harry The U. S. Food and Drug Administration recently approved a first of its kind implant to treat heroin and prescription painkiller abuse. The probuphine implant is about the size of a matchstick and administers buprenorphine for six months, a drug that helps ease opioid cravings. “We are in the midst of an opioid epidemic that is killing 30,000 people a year in the United States,” said Richard Rosenthal, MD, a professor of psychiatry at the Icahn School of Medicine at Mount Sinai, who led a clinical trial of the drug. Dr. Rosenthal believes the probuphine implant may be a game-changer for addiction treatment. - Richard Rosenthal, MD, Professor, Psychiatry, Icahn School of Medicine at Mount Sinai, Medical Director, Addition Psychiatry, Mount Sinai Behavioral Health System Learn more: http://pix11.com/2016/07/21/new-implant-to-aid-patients-in-battle-against-opioid-and- prescription-painkiller-addiction/ Additional Coverage: MD Magazine: http://www.hcplive.com/medical-news/buprenorphine-implant-helps-opioid- dependence-better-than-standard-method

Australia Broadcasting Corporation – July 21 Kidney Transplant Organ Failure Risk Can Now Be Predicted Due To “Landmark” Research— Stephanie Dalzell and Sarah Sedghi Experts at Sydney's Westmead Institute and the Icahn School of Medicine at Mount Sinai have isolated 13 genes that can predict whether patients are at risk of organ damage after a kidney transplant. The researchers used genomic sequencing to test 40,000 genes from biopsies of transplanted kidneys. They compared the gene regulation between people who had normal kidney function after a transplant, and people who showed signs of organ failure. Using a series of complex mathematical equations, they then managed to identify 13 genes that were predictive of poor kidney function in the future. - Icahn School of Medicine at Mount Sinai Learn more: http://www.abc.net.au/news/2016-07-22/kidney-transplant-risk-can-be-predicted-after- landmark-research/7653850 Additional Coverage: The Sydney Morning Herald: http://www.smh.com.au/national/health/genetic-test-can-identify- patients-most-at-risk-of-kidney-rejection-20160721-gqacq5.html

ABC News – July 22 What a Brain Surgeon's Virtual Reality Tool and Pokemon Go Have in Common — Gillian Mohney Joshua Bederson, MD, chairman of neurosurgery for Mount Sinai Health System, spent his Tuesday morning this week calmly working his way through the brain of a 47-year-old patient. Dr. Bederson was using a new technology called CaptiView, which he believes could be the future of brain surgery. "We’re bringing together several different technologies in this surgery. The first is 3-D visualization of the aneurysm in a way that simulates the actual anatomy a little more accurately than we have done in the past," he told ABC News before the surgery.” - Joshua Bederson, MD, Professor, Neurosurgery, Icahn School of Medicine at Mount Sinai, System Chair, Neurosurgery, Mount Sinai Health System Learn more: http://abcnews.go.com/Health/brain-surgeons-virtual-reality-tool-pokemon- common/story?id=40781190

Time Warner Cable News – July 20 Medicated Beads Offer Targeted Approach to Fighting Liver Cancer — Bee Driscoll Liver cancer is the second most deadly type of cancer, in part, because it is especially difficult to treat. But a new treatment at The Mount Sinai Hospital is allowing doctors like Edward Kim, MD, director of interventional oncology at The Mount Sinai Hospital, to deliver chemotherapy-coated beads directly into the tumor. Dr. Kim delivers the LUMI beads using a catheter threaded through the wrist. “You can see them directly under x-rays, so where we inject these LUMI beads we can see exactly where we’re going,” said Dr. Kim. - Edward Kim, MD, Associate Professor, Radiology, Surgery, Icahn School of Medicine at Mount Sinai, Director, Interventional Oncology, The Mount Sinai Hospital Learn more: http://www.ny1.com/nyc/all-boroughs/health-and-medicine/2016/07/20/liver-cancer-bead- treatment-.html

Newsweek – July 21 Navigating Cancer As A Trans Person Is A Nightmare — Colleen Curry Discomfort—or blatant discrimination—on the part of doctors and nurses is just one of a host of factors that make catching and treating cancer a challenge in the trans population. Zil Garner Goldstein, FNP- BC, program director of the Center for Transgender Medicine and Surgery, shares her perspective in a companion video interview. “If you think about the entire basis of the medical system it really has transphobia built into from the ground up,” said Goldstein. “One of the first questions you encounter when you go into a medical practice is are you male or are you female. If you’re transgender you don’t necessary know what to answer to that question.” - Zil Garner Goldstein, FNP-BC, Program Director, Center for Transgender Medicine and Surgery at Mount Sinai Learn more: http://www.newsweek.com/2016/07/29/cancer-transgender-health-hormone-therapies- 482423.html

Medpage Today – July 21 MenB Vax Not Fully Effective in College Outbreak — Molly Walker One-third of college students vaccinated for group B meningococcal disease during an outbreak on campus produced no immune response to the outbreak strain, though nearly all responded to the two strains included in the vaccine, researchers examining the December 2013 outbreak at Princeton University found. "Interestingly, a subset of vaccinated students who did not meet titer thresholds did in fact become seropositive to the novel reference strains," said Michelle Cespedes, MD, an associate professor of infectious disease at the Icahn School of Medicine at Mount Sinai. "This suggests that the standard measure of vaccine response may not be an accurate measure of protection for this vaccine and the series may require a third dose." - Michelle Cespedes, MD, Associate Professor, Medicine, Infectious Disease, Icahn School of Medicine at Mount Sinai Learn more: http://www.medpagetoday.com/infectiousdisease/vaccines/59237

Yahoo! Beauty – July 21 Sen. Chuck Schumer Says Consumers Are Getting Burned by Sunscreen Manufacturers. Here’s How to Protect Yourself — Jenna Birch You might feel safe buying sunscreen with a high SPF (sun protection factor), but New York Sen. Chuck Schumer says, not so fast. Citing a recent study from Consumer Reports, he says Americans are getting burned by manufacturers that aren’t delivering on their labels’ promises. “Correct sunscreen use involves applying 30 minutes before sun exposure, when most apply the product while in the sun already,” said Gary Goldenberg, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai. “Use approximately one ounce of sunscreen for an average-size person; most people do not apply enough - Gary Goldenberg, MD, Assistant Professor, Dermatology, Pathology, Icahn School of Medicine at Mount Sinai, Director, Dermatology Faculty Practice, The Mount Sinai Hospital Learn more: https://www.yahoo.com/beauty/senator-chuck-schumer-says-consumers-are-getting- 205046745.html

LA Times – July 20 Dave Roberts Says Surgery Is Still A Possibility For Clayton Kershaw — Andy McCullough Pitcher Clayton Kershaw may have to face back surgery to fix a herniated disk. “In the absence of having a lot of buttock pain or leg pain, we typically counsel athletes not to have surgery for that problem,” said Andrew Hecht, MD, chief of spine surgery at the Mount Sinai Health System. “We don’t usually do micro-diskectomy surgeries on people with back pain only.” - Andrew Hecht, MD, Associate Professor, Orthopaedics, Neurosurgery, Icahn School of Medicine at Mount Sinai, Chief of Spine Surgery for the Mount Sinai Health System and The Mount Sinai Hospital, Director of The Spine Hospital at Mount Sinai Learn more: http://www.latimes.com/sports/dodgers/la-sp-dodgers-kershaw-wood-20160720-snap- story.html

Endocrine Web – July 21 Exercise Program Improves Cardiopulmonary Fitness and Reduces Waist Circumference in Postmenopausal Women With Nonalcoholic Fatty Liver Disease — Kristin Della Volpe A 24-week structured exercise training program for postmenopausal women with nonalcoholic fatty liver disease (NAFLD) significantly improved waist circumference, high-density lipoprotein cholesterol levels, and cardiopulmonary fitness. "Two of the things that are most important in treating fatty liver disease are diet and exercise," commented Douglas Dietrich, MD, professor of medicine at the Icahn School of Medicine at Mount Sinai. "However, without structure most patients fail to implement either of these programs." - Douglas Dietrich, MD, Professor, Medicine, Liver Disease, Director, Continuing Medical Education, Icahn School of Medicine at Mount Sinai Learn more: http://www.endocrineweb.com/professional/obesity/exercise-program-improves- cardiopulmonary-fitness-reduces-waist-circumference-p

Organic Life – July 15 9 Breakfast Foods You Should Never Buy — Rebecca Straus Simply eating something for your morning meal isn’t good enough to get you going and keep your energy levels high throughout the day. “The ideal breakfast contains a whole grain carbohydrate, a protein, and fresh fruit or vegetable,” says Laura Manning, RD, MPH, a clinical nutrition coordinator at The Mount Sinai Hospital. “The perfect example is a bowl of whole grain oats with chopped walnuts and blueberries.” - Laura Manning, RD, MPH, Clinical Nutrition Coordinator, Medicine, Gastroenterology, The Mount Sinai Hospital Learn more: http://www.rodalesorganiclife.com/food/9-breakfast-foods-you-should-never-buy

Self – July 14 7 Things Everyone Gets Wrong About UTIs — Amy Marturana Urinary tract infections can be painful and frustrating to treat, and most women can expect to have at least one. “Women didn’t die of UTIs before antibiotics. They just had more pain,” says Lisa Dabney, MD, the director of urogynecology at Mount Sinai West. A mild UTI could potentially go away on its own. The problem is that UTIs have become harder to treat, thanks to increasing antibiotic-resistance of the most common bacteria that causes them. - Lisa Dabney, MD, Director, Urogynecology, Department of Obstetrics and Gynecology, Mount Sinai West Learn more: http://www.self.com/wellness/2016/07/7-urinary-tract-infection-uti-myths/

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Stephanie Sherman Subject: Mount Sinai In The News - July 21, 2016 Date: Thursday, July 21, 2016 1:06:04 PM Attachments: ATT00002.txt

In the News July 21, 2016

Managed Care – July 20 Study Supports Use of Buprenorphine Implants for Opioid Dependence While buprenorphine has long been used to treat adults with opioid dependence, its efficacy can be hindered by the lack of adherence to daily, sublingual doses of the medication. New research led by the Icahn School of Medicine at Mount Sinai and published online in the Journal of the American Medical Association has shown that a higher percentage of stable, opioid-dependent patients given six-month buprenorphine implants remained abstinent compared with patients given the medication sublingually. “There are some individual and public health risks with daily dosing of sublingual buprenorphine, such as missed doses and accidental pediatric exposure, as well as the risk of theft or intentional diversion,” said Richard N. Rosenthal, MD, a professor of psychiatry at the Icahn School of Medicine at Mount Sinai. “Given that transitioning to implants did not lead to increased craving or withdrawal symptoms and that the implants remained in place over the active treatment period, buprenorphine implants are an opportunity to reduce adherence issues and may improve efficacy in stable patients with opioid dependence.” - Richard Rosenthal, MD, Professor, Psychiatry, Icahn School of Medicine at Mount Sinai, Medical Director, Addition Psychiatry, Mount Sinai Behavioral Health System Learn more: http://www.managedcaremag.com/news/study-supports-use-buprenorphine-implants- opioid-dependence Additional Coverage: http://journalstar.com/lifestyles/health-med-fit/implant-proves-effective-at-combating-opioid- dependence/article_6e841222-b4e0-5ab5-b3a4-cadd0b6c6694.html http://www.2minutemedicine.com/buprenorphine-implants-more-likely-than-sublingual-delivery-to- prevent-opioid-relapse/ https://www.pharmacist.com/buprenorphine-implants-may-improve-opioid-abstinence-among-adults- opioid-dependence https://www.sciencedaily.com/releases/2016/07/160719123019.htm http://www.neurologyadvisor.com/pain/buprenorphine-implant-effective-for-reducing-opioid- dependence/article/510757/

Politico New York – July 21 What Works — Dan Goldberg Researchers at the Icahn School of Medicine at Mount Sinai wanted to find out if six-month subdermal buprenorphine implants were better than sublingual buprenorphine. "Buprenorphine is an effective treatment for opioid dependence; however, adherence to daily dosing for management of chronic disorders is challenging, the authors said." - Icahn School of Medicine at Mount Sinai Learn more: No web link available.

Everyday Health — July 18 A New Way to Fight Fat -- Blocking the ‘Hunger Hormone’ — Dr. Sanjay Gupta A 235- pound, five-one woman.is participating in an experiment. If it works, we may have a whole new way to treat obesity, by permanently reducing appetite. In a recent interview, Aaron Fischman, associate professor of radiology and surgery at Icahn School of Medicine at Mount and lead investigator said, “ This is completely new, in terms of treating obesity using this technique. Really what we want to do is we want to control what controls your appetite, because appetite can go up and down during the day. It can depend on your mood. But really what controls our appetite, what we’ve learned over the years, is hormones.” - Aaron Fischman, MD, Associate Professor, Radiology, Surgery, Icahn School of Medicine at Mount Sinai, Program Director, Vascular and Interventional Radiology, Mount Sinai Health System Learn more: http://www.everydayhealth.com/sanjay-gupta/new-way-fight-fat-blocking-hunger- hormone/

The Denver Post– July 20 Baby Teeth Contain Clues About Early Exposure To Toxins — Rachel Cernansky Baby teeth may soon be worth a lot more than the sentimental value they offer nostalgic parents. It turns out that these teeth store a unique type of health record, with the potential to reveal everything that an individual has been exposed to, including environmental toxins such as lead and pesticides, and stress hormones produced by the baby in utero. It may sound like science fiction, but it’s the key to much of Manish Arora’s BDS, MD, PhD, associate professor of preventive medicine, assistant professor of dentistry, and director of exposure biology at Icahn School of Medicine at Mount Sinai, work. Arora explains that “teeth form rings as they grow — just as trees do, but daily instead of annually — and each ring contains information about exposures that occurred on the day it was formed. Using specialized equipment, he has developed ways to analyze what’s contained in those rings.” He often describes teeth “as biologic hard drives.” - Manish Arora, BDS, MD, PhD, Associate Professor, Preventive Medicine, Assistant Professor, Dentistry, Director, Exposure Biology, Icahn School of Medicine at Mount Sinai Learn more: http://www.denverpost.com/2016/07/21/baby-teeth-contain-clues-about-early-exposure-to- toxins/

CBS News New York – July 20 Advanced, Incurable Prostate Cancer Is On the Rise – Experts Are Trying To Figure Out Why – Dr. Max Gomez There has been an alarming spike in the number of men diagnosed with advanced or incurable prostate cancer. Ketan Badani, MD, professor of urology, Icahn School of Medicine at Mount Sinai says, “The biology of prostate cancer has gotten worse over time. Whereas it used to be a little less of an aggressive disease, over the time it’s become worse. Men who have metastatic prostate cancer will have higher PSAs than those who don’t, but these men have even higher PSAs than what we typically see which points to a worse biology of cancer,” - Ketan Badani, MD, Professor, Urology, Icahn School of Medicine at Mount Sinai, Vice Chairman, Urology, Robotic Operations, Director, Comprehensive Kidney Cancer Center , Mount Sinai Health System, Director, Robotic Surgery, Mount Sinai St. Luke’s and Mount Sinai West Learn more: http://newyork.cbslocal.com/2016/07/20/prostate-cancer-2/

Market Watch – July 20 Mylan’s Epipen Price Increases Are Valeant-Like In Size, Shkreli-Like In Approach — Emma Court The story is an all-too-familiar one: company buys dated drug, raises prices and impedes patient access to life-saving treatment in the process. The price of the EpiPen, which treats emergency allergic reactions, has climbed sixfold over the last several years. Beth Corn, MD, associate professor of medicine at Icahn School of Medicine at Mount Sinai stated, “Until there’s a better alternative, anyone relegated to an EpiPen is going to be carrying it to a very distant future.” - Beth Corn, MD, Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai Learn more: http://www.marketwatch.com/story/mylans-epipen-price-increases-are-valeant-like-in- size-shkreli-like-in-approach-2016-07-20

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

This message and any attachments are confidential and intended solely for the use of the individual or entity to which they are addressed. If you are not the intended recipient, you are prohibited from printing, copying, forwarding, saving, or otherwise using or relying upon them in any manner. Please notify the sender immediately if you have received this message by mistake and delete it from your system. From: ITNDaily on behalf of Stephanie Sherman Subject: Mount Sinai In the News - July 20, 2016 Date: Wednesday, July 20, 2016 2:04:25 PM Attachments: ATT00003.txt

In the News July 20, 2016

Forbes – July 19 How Buprenorphine Implants Help People Fight Opioid Addiction – CJ Arlotta Poor medication adherence can lead to reduced treatment benefits, even death in some cases. Implants are being used by some medical professionals to increase the likelihood of patients “following the doctor’s orders.” Specifically, some clinicians are using these devices in individuals with an addiction to opioids. This treatment option may also be considered an effective relapse prevention tool. Icahn School of Medicine at Mount Sinai researchers found that 86% of participants receiving implants maintained abstinence from opioids over a period of six months, compared to 72% receiving sublingual buprenorphine. -Icahn School of Medicine at Mount Sinai Learn more: http://www.forbes.com/sites/cjarlotta/2016/07/19/opioid-abstinence-using-buprenorphine- implants/#3313086b3ff5

UPI – July 19 Implant Effective Treatment For Opioid Addiction, Study Says— Stephen Feller Researchers found an implant that delivers buprenorphine may work as well for patients in treatment for opioid dependency as other forms of the medication. Richard Rosenthal, MD, medical director of Addiction Psychiatry for the Mount Sinai Behavioral Health System, who led the new study comparing the implant with oral doses, said for patients who have been stable in their treatment -- no relapses, properly maintaining their prescribed medications -- the implant has the potential to be a big help because there is no way to alter dosing. - Richard Rosenthal, MD, Professor, Psychiatry, Icahn School of Medicine at Mount Sinai, Medical Director, Addition Psychiatry, Mount Sinai Behavioral Health System Learn more: http://www.upi.com/Health_News/2016/07/19/Implant-effective-treatment-for-opioid- addiction-study-says/4851468939679/

Fierce Biotech – July 19 FDA Panel Gives Cautious Nod To Valeant Psoriasis Drug, Despite Suicide Concerns - Stacy Lawrence An FDA advisory committee recommended that the agency approve Valeant’s brodalumab to treat moderate-to-severe plaque psoriasis. But it also advised that the biopharma implement additional risk- management options for suicidal ideation--which had proved to be a problem in Phase III testing. "Brodalumab is an extraordinary drug that has meaningfully improved the quality of life of some of my most difficult-to-treat psoriasis patients, many of whom achieved complete skin clearance with this treatment," said Mark Lebwohl, MD, chairman of the Department of Dermatology at Icahn School of Medicine at Mount Sinai, in a statement. He was a lead investigator in Phase III testing. - Mark Lebwohl, MD, Professor, Chair, Dermatology, Icahn School of Medicine at Mount Sinai, System Chair, Dermatology, Mount Sinai Health System Learn more: http://www.fiercebiotech.com/biotech/fda-panel-gives-cautious-nod-to-valeant-psoriasis- drug-despite-suicide-concerns

El Diario Vasco – July 20 Laia Sanz, Valentín Fuster Y Joan Roca, Premiados Por Sport Cultura Barcelona Valentin Fuster, MD, PhD, director of Mount Sinai Heart, is a recipient of the Sport Cultura Barcelona Awards. Dr. Fuster received the award for the “best path”. He currently combines his duties as CEO of the National Center for Cardiovascular Research Carlos III in Madrid, and at Mount Sinai Heart. - Valentin Fuster, MD, Professor, Medicine, Cardiology, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute, the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health Learn more: http://www.diariovasco.com/agencias/201607/20/laia-sanz-valentin-fuster- 732221.html

Diagnostic Imaging – July 20 Annual CT, Not Biopsy for Nonsolid Nodules in Lung Cancer Screening - Diagnostic Imaging Staff Lung cancers that manifest as nonsolid nodules (NSNs) as seen on CT lung cancer screening have an indolent course and can be managed with annual CT follow-up. Researchers from Icahn School of Medicine at Mount Sinai, sought to validate the recommendation of annual follow-up examinations following identification of NSNs by CT lung cancer screening. “The causes of death in this group were likely due to another solid or part-solid nodule in the same lobe of the lung,” lead author Rowena Yip, MPH, senior biostatistician at Icahn School of Medicine at Mount Sinai, said. - Rowena Yip, MD, MPH, Senior Biostatistician, Radiology, Icahn School of Medicine at Mount Sinai Learn more: http://www.diagnosticimaging.com/low-dose/annual-ct-not-biopsy-nonsolid-nodules- lung-cancer-screening

Life Hack – July 20 5 Ways to Take Care of Your Voice – Ana Johanson Losing your voice — even for just a few hours — can be extremely debilitating and frustrating. It’s one of those things you take for granted until it’s gone. But when it goes, you suddenly realize just how useless you are. Unfortunately, the only people who ever do anything to prevent issues and protect their voices are entertainers, singers, and professional speakers. This leaves the rest of the population susceptible to problems. This is why coaches who frequently yell and scream often lose their voices or deal with issues later in life. “Usually, it’s just a temporary thing that goes away,” says Dr. Michael Pitman of the Mount Sinai Health System. “But sometimes, as the vocal cords try to repair themselves — and you strain and push your voice even harder — that’s where you get into a vicious cycle of vocal decompensation. The more you try and compensate, the more damage you do.” - Michael Pitman, MD, Associate Professor of Otolaryngology, Icahn School of Medicine at Mount Sinai Learn more: http://www.lifehack.org/428117/5-ways-to-take-care-of-your-voice

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

This message and any attachments are confidential and intended solely for the use of the individual or entity to which they are addressed. If you are not the intended recipient, you are prohibited from printing, copying, forwarding, saving, or otherwise using or relying upon them in any manner. Please notify the sender immediately if you have received this message by mistake and delete it from your system. From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 19, 2016 Date: Tuesday, July 19, 2016 11:15:15 AM Attachments: ATT00002.txt

In the News July 19, 2016

Medpage Today – July 18 Early Hybrid Coronary Revascularization Outcomes Promising — Nicole Lou Hybrid coronary revascularization--pairing coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of other vessels--may be feasible in a selected group of patients, a multi-center study showed. Adjusting for baseline risk, the rates of death, stroke, myocardial infarction, and repeat revascularization combined were no different between the hybrid and PCI-only groups, wrote John D. Puskas, MD, a professor of cardiovascular surgery at the Icahn School of Medicine at Mount Sinai, and colleagues in their study. "A randomized trial with long- term outcomes is needed to definitively compare the effectiveness of these two revascularization strategies," Dr. Puskas' group urged. - John D. Puskas, MD, Professor, Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, Chair, Department of Cardiovascular Surgery, Mount Sinai Beth Israel, Director, Surgical Coronary Revascularization, Mount Sinai Health System Learn more: http://www.medpagetoday.com/cardiology/pci/59145

I4U News – July 18 Brain Cells For Emotional Memory May Help Us Learn Fear — Luigi Lugmayr The specialized nerve cells in our brain that are responsible for emotional memory also play an important role in fear learning, say researchers. The team from the Icahn School of Medicine at Mount Sinai set out to identify the synaptic connections between brain's inhibitory cells called parvalbumin- interneurons (PV-INs), sensory pathways and neighboring principal neurons in a brain region involved in detecting and responding to dangerous situations. They found that the sparse but potent population of PV-INs in the amygdala region of the brain influence fear memory encoding—the process responsible for persistent reactions to trauma-associated cues. "Our study is the first to show that this default silencing may, in part, be attributable to a sparse population of inhibitory PV-INs," said Roger Clem, PhD, an assistant professor of neuroscience at the Icahn School of Medicine at Mount Sinai. - Roger Clem, PhD, Assistant Professor, Neuroscience, Psychiatry, Icahn School of Medicine at Mount Sinai Learn more: http://www.i4u.com/2016/07/113450/brain-cells-emotional-memory-may-help-us-learn-fear

Oncology Nurse Advisor – July 18 Annual Follow-up With Low-Dose CT Is Sufficient for Some Lung Nodules — Kathy Boltz For nonsolid nodules identified by computed tomography (CT) screening for lung cancer, annual screening with low-dose CT can eliminate the need for biopsy or surgery. "When you biopsy a nonsolid nodule, it's usually premalignant, noninvasive, or due to some other cause like infection or fibrosis," said Claudia Henschke, MD, PhD, a clinical professor of radiology at the Icahn School of Medicine at Mount Sinai, and co-author of the study. The researchers found that, among the 26,722 participants, 2534 (9.4%) had one or more NSNs. Of those, 48 died of lung cancer, yet 21 of those 48 had no NSNs in the cancerous lobe of the lung. A review of the remaining 27 cases found that death was unlikely to be caused by the NSN, as long as annual follow-up was done. "The causes of death in this group were likely due to another solid or part-solid nodule in the same lobe of the lung," said study lead author Rowena Yip, MPH, a senior biostatistician at the Icahn School of Medicine at Mount Sinai. - Claudia Henschke, MD, PhD, Clinical Professor, Radiology, Icahn School of Medicine at Mount Sinai, Chief, Lung and Cardiac Screening Program, The Mount Sinai Hospital - Rowena Yip, MPH, Senior Biostatistician, Radiology, Icahn School of Medicine at Mount Sinai Learn more: http://www.oncologynurseadvisor.com/lung-cancer/annual-low-dose-ct-is-sufficient-for- some-lung-nodules/article/510038/

Politico New York – July 19 Marking the Spot — Dan Goldberg Researchers from the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have a new method for analyzing multiple tissue markers to better understand which cancers will respond to immunotherapies. It is called multiplexed immunohistochemical consecutive staining on a single slide, or MICSSS, according to a study in the journal Science Immunology. - Icahn School of Medicine at Mount Sinai Learn more: No web link available.

Modern Healthcare – July 18 Hospitals Have Been Preparing to Comply With Anti-Discrimination Rule — Virgil Dickson In May, HHS finalized a rule that protects transgender patients from being discriminated against because of their gender or gender identity. Beginning July 18, transgender people should be able to enter bathrooms or hospital wards consistent with their gender identity. Mount Sinai Health System has also taken these steps, said Barbara Warren, PsyD, director for LGBT Programs and Policies in the Office for Diversity and Inclusion at Mount Sinai Health System. “A lot of healthcare systems want to attract transgender patients,” Warren said. “There is competition in healthcare for patients, and a lot of healthcare systems need to be able to offer equitable and competent care to diverse patient populations." - Barbara E. Warren, PsyD, Director, LGBT Health Services, Mount Sinai Beth Israel, Mount Sinai Health System Learn more: http://www.modernhealthcare.com/article/20160718/NEWS/160719912

Healio’s HemOnc Today – July 18 BTK Inhibitors, Vaccines Top Contenders For Combination Immune Strategies in Lymphoma In the final segment of a multi-part video interview, Joshua Brody, MD, director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai, covers positive results seen using anti-PD-1 antibodies in conjunction with targeted therapies — specifically Bruton’s tyrosine kinase (BTK) inhibitors — and the potential impact of their seemingly “synergistic” relationship. However, he underscores there remains the conundrum of converting patients who are not responsive to anti-PD-1 antibodies to responders, noting this requires a “kick start” to the immune system. “If these are able to cure lymphoma, we would be delighted,” Dr. Brody says. “If they are able to push off a patient’s need for chemotherapy, radiation therapy or other standard therapies, that would still be pretty gratifying.” - Joshua Brody, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Director, Lymphoma Immunotherapy Program, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai Learn more: http://www.healio.com/hematology-oncology/lymphoma/news/online/%7B85412b8e-8a4d- 4258-98d0-19c6bee2682d%7D/video-btk-inhibitors-vaccines-top-contenders-for-combination-immune- strategies-in-lymphoma

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 18, 2016 Date: Monday, July 18, 2016 11:00:52 AM Attachments: ATT00002.txt

In the News July 18, 2016

New Kerala – July 18 Brain Cells For Emotional Memory May Help Us Learn Fear Stimuli encountered during a traumatic event can elicit strong emotional reactions long after the threat has subsided. These emotional memories are thought to be encoded through changes in the neural connections or synapses, within the basolateral amygdala that provide outputs to other brain areas, controlling the so-called "fight or flight" response. "The complex anatomy of these cells may allow them to function like master regulators on a hair trigger, springing into action to suppress their neighbors when they detect even the slightest sensory perturbation," said Roger Clem, PhD, an assistant professor of neuroscience at the Icahn School of Medicine at Mount Sinai. - Roger Clem, PhD, Assistant Professor, Neuroscience, Psychiatry, Icahn School of Medicine at Mount Sinai Learn more: http://www.newkerala.com/news/2016/fullnews-91941.html Additional Coverage: Science Codex: http://www.sciencecodex.com/specialized_neurons_in_emotional_memory_brain_area_play_important_role_in_fear- 186334

Marketplace – July 18 Transgender Patients Protected Under Health Care Rules — Dan Gorenstein Under a new policy from the U.S. Department of Health and Human Services, doctors and hospitals that receive federal funding face penalties if they discriminate against people based on their gender or their gender identity. One study shows 70 percent of transgender people have experienced discrimination in health care. “This is for their safety, their comfort, basically to respect who they are,” said Barbara Warren, PsyD, director for LGBT Programs and Policies in the Office for Diversity and Inclusion at Mount Sinai Health System. - Barbara E. Warren, PsyD, Director, LGBT Health Services, Mount Sinai Beth Israel, Mount Sinai Health System Learn more: http://www.marketplace.org/2016/07/15/world/transgender-patients-protected-under-healthcare-rules Additional Coverage: WBEZ-FM Chicago: No web link available.

Politico New York – July 18 Making Rounds — Dan Goldberg Sandeep P. Kishore, MD, PhD, an assistant professor of health system design and global health at the Icahn School of Medicine at Mount Sinai, has been elected to a five-year term as a member of the Council on Foreign Relations. - Sandeep Kishore, MD, PhD, Assistant Professor, General Internal Medicine, Health System Design and Global Health, Associate Director, Arnhold Global Health Institute, Icahn School of Medicine at Mount Sinai Learn more: No web link available.

Medical Xpress – July 18 Birth Control Options For Women Over 40 Other Than The Pill — Barbara Sadick Almost one quarter of women in the United States between ages 15 and 44 use the birth control pill to prevent pregnancy. Some doctors advise against continuing its use after age 40, but women need to protect themselves against unwanted pregnancy until one year after menopause. Gillian Dean, MD, MPH an associate professor of obstetrics, gynecology and reproductive science at the Icahn School of Medicine at Mount Sinai, said women have more options than ever when reassessing their birth control choices. "The methods I discuss most are the most effective and easiest to use: the IUD and the implant. But if I have a healthy nonsmoking patient who wants to stay on pills, I counsel her that it's a safe and effective option all the way until menopause," she said. - Gillian Dean, MD, MPH, Associate Professor, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, Director, Fellowship in Family Planning Learn more: http://medicalxpress.com/news/2016-07-birth-options-women-pill.html

PIX 11 – July 16 Hot Summer Days in NYC Bring Back Stinky Smell on Streets — Allison Kaden There's a reason why a whiff of an overflowing garbage can or mysterious puddle of street grime can turn your stomach on a hot day. According to Benjamin Tweel, MD, an assistant professor of otolaryngology at the Icahn School of Medicine at Mount Sinai, there is science behind the stink. Smells are more pronounced in the heat because there is actually more smell in the air. A good example of this is food when you are cooking. "When you take it out of the refrigerator, it's cold. It doesn't smell but when you heat it up those molecules are released more into the air. It smells more," Dr. Tweel said. - Benjamin Tweel, MD, Assistant Professor, Otolaryngology, Icahn School of Medicine at Mount Sinai Learn more: http://pix11.com/2016/07/15/hot-summer-days-in-nyc-bring-back-stinky-smell-on-streets/

WABC – July 13 Health Alert: Sleep Wrinkles Recently published research suggests that facial distortion while sleeping can cause skin to age more quickly. “When your skin is against any surface, you have folding of the skin,” said Joshua Zeichner, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai. “That leads to etching in of lines that can then become permanent.” - Joshua Zeichner, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director, Cosmetic and Clinical Research in Dermatology, The Mount Sinai Hospital Learn more: No web link available.

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 15, 2016 Date: Friday, July 15, 2016 11:45:30 AM Attachments: ATT00002.txt

In the News July 15, 2016

Modern Healthcare – July 14 Wealthy White Men More Likely To Get Robotic Surgery — Adam Rubenfire Research suggests there may be gender, racial and socioeconomic disparities when it comes to robotic surgery. The patient base for robot-assisted laparoscopic surgery skews white, male and wealthy, and the physicians performing those surgeries tend to be male, young and graduates of U.S. medical schools, especially in the state of New York, according to a recent study from New York City-based Mount Sinai Health System. “I think what this study does is it opens our eyes to how care is really being delivered at the forefront of healthcare,” said Michael Palese, MD, chair of the department of urology at Mount Sinai Beth Israel. “Common healthcare is the norm, the standard of care that everyone should get it. But in the beginning stages of new technology and surgical procedures, who is really benefiting from these things? ” - Michael Palese, MD, Associate Professor, Urology, Icahn School of Medicine at Mount Sinai, Chair, Department of Urology, Mount Sinai Beth Israel, Director, Minimally Invasive Surgery, Mount Sinai Health System Learn more: http://www.modernhealthcare.com/article/20160714/NEWS/160719927

Drug Discovery and Development – July 15 Simple Method to Characterize Immune Cells in Tumors Researchers at The Tisch Cancer Institute (TCI) at the Icahn School of Medicine at Mount Sinai have developed a new method of analyzing multiple tissue markers using only one slide of a tumor section to better understand immune response occurring locally. "Our goal was to get a better understanding of immunologic responses at the tumor site while addressing the need for high-dimensional analysis using as little tissue as possible," said Sacha Gnjatic, PhD, an associate professor of immunology, hematology, and medical oncology at the Icahn School of Medicine at Mount Sinai, who was the senior co-author of this study with Miriam Merad, MD, PhD, a professor of oncological sciences at the Icahn School of Medicine at Mount Sinai. "The MICSSS technique helps us characterize the distribution of complex cell subsets in tumor tissues without cross-reactivity between staining cycles," said lead author Romain Remark, PhD, a postdoctoral fellow working in the laboratories of Dr. Gnjatic and Dr. Merad. - Miriam Merad, MD, PhD, Professor, Oncological Sciences, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai - Sacha Gnjatic, PhD, Associate Professor, Immunology, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai - Romain Remark, PhD, Postdoctoral Fellow, Icahn School of Medicine at Mount Sinai Learn more: https://www.dddmag.com/news/2016/07/simple-method-characterize-immune-cells- tumors

Politico New York – July 15 Science of Fear — Dan Goldberg Cells in the amygdala called parvalbumin-interneurons are responsible for hardwiring fear into our brains after a traumatic event, according to a study published in Neuron by researchers from the Icahn School of Medicine at Mount Sinai. - Icahn School of Medicine at Mount Sinai Learn more: No web link available.

Healio’s HemOnc Today – July 14 James L. M. Ferrara, MD, DSc, reviews “long-standing problem” of GVHD after allogeneic HSCT Graft-versus-host disease is “the major complication” associated with allogeneic hematopoietic stem cell transplantation for the treatment of leukemia, according to James Ferrara, MD, senior faculty in hematology and oncology at the Icahn School of Medicine at Mount Sinai. Dr. Ferrara discusses the efficacy of allo-HSCT as well as the prevalence of GVHD and related complications. GVHD is “the major barrier” to more widespread use of allo-HSCT for high-risk leukemia and a “long-standing problem,” according to Ferrara: “We’ve known about it for half a century.” - James Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine, Professor and Director of Hematologic Malignancies Translational Research Center at the Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Learn more: http://www.healio.com/hematology-oncology/leukemia/news/online/%7B46338450-a2d2- 41b7-a866-2e99b1d53035%7D/video-james-l-m-ferrara-md-dsc-reviews-long-standing-problem-of- gvhd-after-allogeneic-hsct

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 14, 2016 Date: Thursday, July 14, 2016 11:36:43 AM Attachments: ATT00002.txt

In the News July 14, 2016

Healthcare Business Daily News – July 13 Link Found Between Traumatic Brain Injury And Late-Life Parkinson’s — But Not Alzheimer’s Traumatic brain injury (TBI) with a loss of consciousness may be associated with later development of Parkinson’s disease but not Alzheimer’s disease or incident dementia, according to a recent study. These findings suggest that clinicians may be misdiagnosing late-life TBI-related neurodegeneration as Alzheimer’s disease, and therefore treatment targeting Alzheimer’s would be ineffective in helping late- life decline. “We want to identify and treat post-TBI neurodegeneration while people are still alive, but to do this, we need to first understand the disease,” said researcher Kristen Dams-O’Connor, PhD, co- director of the Brain Injury Research Center of Mount Sinai. - Kristen Dams-O’Connor, PhD, Associate Professor, Rehabilitation Medicine, Co-Director, Brain Injury Research Center of Mount Sinai, Icahn School of Medicine at Mount Sinai Learn more: https://www.dotmed.com/news/story/31926

Oncology Nurse Advisor – July 13, 2016 Epigenetic Regulator of Tumorigenesis Suggests New Strategies Against Breast Cancer – Kathy Boltz The protein CBX8 uses a previously unknown mechanism to promote the origin of breast tumors, or tumorigenesis, in the most lethal forms of breast cancer, according to new research. "Looking beyond traditional genetics is critical because we have learned that epigenetic factors, the protein CBX8 in this case, are required for tumorigenesis and malignant phenotypes of breast cancer cells," said Emily Bernstein, PhD, an associate professor of oncological sciences and dermatology at the Icahn School of Medicine at Mount Sinai. "We also know that CBX8 is overexpressed in primary breast tumors, and that high CBX8 expression in patients correlates with poor outcome." This focus on epigenetics is an important counterbalance to the lingering public perception that “genes are destiny.” - Emily Bernstein, PhD, Associate Professor, Oncological Science, Associate Professor, Dermatology, Icahn School of Medicine at Mount Sinai Learn more: http://www.oncologynurseadvisor.com/breast-cancer/previously-unknown-mechanism-of- breast-tumorigenesis-identified/article/509155/

TCT MD – July 13 MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer — Michael Wilson Among MI patients, those who develop heart failure after their event face a much higher risk of developing cancer than those who don’t, according to an observational study. In an accompanying editorial, Paolo Boffetta, MD, MPH, Chief of the Division of Cancer Prevention and Control at the Icahn School of Medicine at Mount Sinai, and Jyoti Malhotra, MD, of the Rutgers Cancer Institute of New Jersey, were quick to rule out the idea that heart failure itself is the culprit. “As the average follow-up period for this study was 5 years, and the median time from MI to cancer diagnosis was 2.8 years, it is unlikely that heart failure is playing a causative role in carcinogenesis, because cancer has a latent period of at least a few years from the time of exposure to the risk factor,” Dr. Malhotra and Dr. Boffetta wrote. - Paolo Boffetta, MD, MPH, Professor, Medicine, Hematology and Medical Oncology, Oncological Services, Preventive Medicine, Associate Director, Population Sciences, Tish Cancer Institute, Chief, Division of Cancer Prevention and Control, Icahn School of Medicine at Mount Sinai Learn more: http://www.tctmd.com/show.aspx?id=135922

Allure – July 12 This Popular Prescription Acne Drug Was Just Approved by the FDA for Over-the-Counter Use— Renee Jacques There is good news for all acne sufferers and Differin Gel 0.1% lovers: The FDA has just approved it for over-the-counter use, and you don't have to wait—the new policy goes into effect immediately. "Topical retinoids are prescribed for almost all patients in the office," says Joshua Zeichner, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai. "They help reduce inflammation in the skin and prevent cells from sticking together within the follicle, which blocks the pores." - Joshua Zeichner, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director, Cosmetic and Clinical Research in Dermatology, The Mount Sinai Hospital Learn more: http://www.allure.com/beauty-trends/blogs/daily-beauty-reporter/2016/07/hand-sanitizer- efficacy.html

The New York Times – July 11 Letter to the Editor: Anti-Obesity Blueprint — Angela Diaz, MD The importance of preventing and reversing obesity in children and teenagers is clear. At the Mount Sinai Adolescent Health Center, we serve over 10,000 low-income young people each year, writes Angela Diaz, MD, MPH, director of the Mount Sinai Adolescent Health Center. As part of our intake for primary care, we ask our patients to assess for themselves the amount they eat, how much physical activity they get, how they feel about their body or shape, and whether they would like to consult a nutritionist. This technique avoids labeling and shaming. - Angela Diaz, MD, MPH, Professor, Pediatrics, Adolescent Medicine, Preventive Medicine, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Adolescent Health Center Learn more: http://www.nytimes.com/2016/07/12/science/letters-to-the-editor.html?_r=0

Queens Gazette – July 13 All Indications Point to Healthy Growth Queens has the best medical care in the city. We and our neighbors in the borough know we do not need to cross the river to get world-class medical care. Mount Sinai Queens has ushered in a new era of 21st century medical care with the unveiling of their majorly upgraded and expanded Stavros Niarchos Foundation Emergency Department. Subsequent phases will open soon, including a new Outpatient Imaging Center; a large, multi-specialty physician practice to be called Mount Sinai Doctors, Queens; new expanded operating rooms; and an Interventional Radiology Suite. - Mount Sinai Queens Learn more: http://www.qgazette.com/news/2016-07- 13/Editorials/All_Indications_Point_To_Healthy_Growth.html

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 13, 2016 Date: Wednesday, July 13, 2016 12:00:16 PM Attachments: ATT00002.txt

In the News July 13, 2016

Black Tie Magazine – July 12 Black Tie International: Aspen Ideas Festival 2016 At the Aspen Ideas Festival 2016, Joshua Brody, MD, director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai; Steven Burakoff, MD, Director of The Tisch Cancer Institute at Mount Sinai; Ross Cagan, PhD, professor of developmental and regenerative biology and oncological sciences at the Icahn School of Medicine at Mount Sinai; and Matthew Galsky, MD, director of genitourinary medical oncology at the Icahn School of Medicine at Mount Sinai, discussed breakthrough in cancer screening and treatment. Kenneth L. Davis, MD, President and CEO of the Mount Sinai Health System, moderated the discussion. - Kenneth L. Davis, MD, President, Chief Executive Officer, Mount Sinai Health System - Joshua Brody, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Director, Lymphoma Immunotherapy Program, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai - Steven Burakoff, MD, Professor, Oncological Science, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Director, The Tisch Cancer Institute at Mount Sinai - Ross Cagan, PhD, Professor, Developmental and Regenerative Biology, Oncological Sciences, Ophthalmology, Senior Associate Dean for the Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai - Matthew Galsky, MD, Associate Professor, Medicine, Hematology and Medical Oncology; Assistant Professor, Urology; Director, Genitourinary Medical Oncology, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai Learn more: http://blacktiemagazine.com/society_july_2016/Aspen_Ideas_Festival_2016.htm

HealthDay News – July 12 More Older Americans Cared for at Home— Steven Reinberger More older Americans with chronic health problems are opting to live at home, relying on help from family, paid caregivers or friends, a new study finds. "The majority of seniors would prefer to stay at home rather than go to a nursing home," said R. Sean Morrison, MD, co-director of the Patty and Jay Baker National Palliative Care Center at the Icahn School of Medicine at Mount Sinai, who was not involved in the study. But the unintended consequence of being cared for at home is the strain it puts on caregivers, added Morrison, who is also with the Icahn School of Medicine at Mount Sinai in New York City. - R. Sean Morrison, MD, Professor, Geriatrics and Palliative Medicine, Anesthesiology, Medicine, Icahn School of Medicine at Mount Sinai, Co-Director, Patty and Jay Baker National Palliative Care Center, Director of the National Palliative Care Research Center, Director, Lilian and Benjamin Hertzberg Palliative Care Institute, The Mount Sinai Hospital Learn more: https://consumer.healthday.com/senior-citizen-information-31/misc-aging-news-10/more- older-americans-getting-care-at-home-712829.html Additional Coverage: Rapid City Journal: http://rapidcityjournal.com/lifestyles/health-med-fit/more-older-americans-cared- for-at-home/article_dcb4b833-a1b3-5656-a5be-94a7d60e2321.html

Medpage Today – July 8 Friday Feedback: Pasta, the New Kale? — Kristen Monaco Reshmi Srinath, MD, an assistant professor of endocrinology, diabetes and bone disease at the Icahn School of Medicine at Mount Sinai, provides commentary on a new study that suggests that Italians who ate a lot of pasta had lower BMI, waist circumference, and waist-to-hip ratio than those with lower intake. “It is important to keep in mind that Italian population may be different from U.S. population and their overall diet, calorie intake, portion sizes, activity levels may be different,” said Dr. Srinath. - Reshmi Srinath, MD, Assistant Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai Learn more: http://www.medpagetoday.com/PrimaryCare/DietNutrition/58971

Fox News – July 8 After Terror Attacks, Civilian Responders More Likely Than Pros to Have PTSD Untrained people helping at the scene of terror attacks are much more likely than trained responders to later develop posttraumatic stress, a Norwegian study finds. During an attack, it is best to rely on professionals whenever possible, said Craig Katz, M,D an associate clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai, who was not involved in the study. Volunteers "should hand off their efforts to the organized responders or join forces with the organized responders as soon as they can," he said. In the long term, mental health should be considered as a major part of disaster planning, Dr. Katz added. - Craig Katz, MD, Associate Clinical Professor, Psychiatry, Medical Education, Icahn School of Medicine at Mount Sinai Learn more: http://www.foxnews.com/health/2016/07/08/after-terror-attacks-civilian-responders-more- likely-than-pros-to-have-ptsd.html

Cosmetic Surgery Times – July 12 Post Breast Augmentation Sensory Changes — Lisette Hilton A recent study describing sensory changes post subfascial breast augmentation, reports that based on his study of 162 consecutive patients, only 4% had sensory loss at the nipple-areolar complexes three months post-op, but more than 16% had diminished sensitivity in the lower outer breast quadrant. However, the entire paper was about the subfascial plane, which is an uncommon breast augmentation approach among U.S. surgeons, commented C. Andrew Salzberg, MD, an associate professor of plastic surgery at the Icahn School of Medicine at Mount Sinai. “Most breast augmentations in this country are either [subpectoral or subglandular],” he said. - C. Andrew Salzberg, MD, Assistant Professor, Surgery, Plastic Surgery, Icahn School of Medicine at Mount Sinai Learn more: http://cosmeticsurgerytimes.modernmedicine.com/cosmetic-surgery-times/news/post- breast-augmentation-sensory-changes

New York Daily News – July 12 Hey Pregnant Moms — Stop Taking Those Prenatal Multivitamins — Nicole Lyn Pesce Prenatal vitamins are a big fat waste of money. A new article from BMJ’s Drug and Therapeutics Bulletin says pregnant women do not need to swallow the cost of these expensive supplements anymore — which can run up to $30 a bottle. “Most of my patients assume they have to take prenatal supplements, but the average person is able to fulfill their (nutritional) needs just by natural intake,” said Joanne Stone, MD, director of maternal fetal medicine for the Mount Sinai Health System. - Joanne Stone, MD, Professor, Obstetrics, Gynecology, Reproductive Science, Icahn School of Medicine at Mount Sinai, Director, Perinatal Ultrasound, Maternal Fetal Medicine, Mount Sinai Health Systems Learn more: http://www.nydailynews.com/life-style/health/hey-pregnant-moms-stop-prenatal- multivitamins-article-1.2708527

Everyday Health – July 12 Why Does Harvey Brody Get So Many Skin Cancers? — Sanjay Gupta Harvey Brody gets skin cancer as often as the rest of us get colds. So why does Mr. Brody get so many skin cancers? There are three factors that determine your risk: your lifetime sun exposure, your genetics, and your immune system, which is where Mr. Brody comes in. Mr. Brody is virtually guaranteed of getting skin cancers, because he's taking drugs to suppress the immune system after a heart transplant in 2014. “He is a transplant patient,” said Hooman Khorasani, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai and Mr. Brody’s dermatologist. ”So all transplant patients tend to get skin cancers because they are on immunosuppressive medications.” - Hooman Khorasani, MD, Assistant Clinical Professor, Dermatology, Chief, Division of Mohs, Reconstructive and Cosmetic Surgery, Icahn School of Medicine at Mount Sinai Learn more: http://www.everydayhealth.com/sanjay-gupta/why-does-harvey-brody-get-many-skin- cancers/

DNAinfo – July 12 Here's What You Need to Know About the Safety of Your Home's Drinking Water — Amy Zimmer As several cities across the country face problems with lead in their water, New York City officials have reaffirmed the safety of the drinking water here and have taken proactive measures to test water at city schools. But lead paint tends to be a bigger issue, especially in buildings constructed before the banning of lead paint in 1977. “The single most important preventive step you can take is to never sand or strip lead paint around vulnerable individuals,” wrote Philip Landrigan, MD, the dean for global health at the Icahn School of Medicine at Mount Sinai, in a recent Daily News op-ed. - Philip Landrigan, MD, MSc, Professor, Preventive Medicine, Pediatrics, Dean for Global Health, Icahn School of Medicine at Mount Sinai Learn more: https://www.dnainfo.com/new-york/20160712/inwood/heres-what-you-need-know-about- safety-of-your-homes-drinking-water

Yahoo! Beauty – July 12 The FDA Just Approved the First-Ever Retinoid for OTC Treatment of Acne — Jenna Birch For decades, countless patients have been prescribed retinoids by their dermatologist to treat acne — a condition affecting some 50 million Americans, according to the American Academy of Dermatology. But, the agency just approved 0.1 percent Differin gel for over-the-counter use, effective immediately. “The FDA regulates OTC products that target acne,” said Joshua Zeichner, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai. “There have been no changes to the FDA’s OTC acne monograph for decades, up until now. OTC treatments for acne were limited to benzoyl peroxide, salicylic acid, and sulfur.” - Joshua Zeichner, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director, Cosmetic and Clinical Research in Dermatology, The Mount Sinai Hospital Learn more: https://www.yahoo.com/beauty/the-fda-just-approved-the-first-ever-retinoid-for- 174422253.html

Metro Newspaper – July 11 How can I protect myself from Zika? — Sheila Dougherty Instead of the usual sunburns and dehydration, summer headlines have been dominated by the Zika virus and the devastating birth defects it can cause when a pregnant woman becomes infected – or when an infected woman becomes pregnant. Metro talked to Brian Koll, MD, executive director of infection prevention and control at Mount Sinai Health System. “The concern at the present point for us is really about the sexual transmission, because we’re not seeing transmission by mosquitoes in the continental United States,” said Dr. Koll. - Brian Koll, MD, Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai, Executive Medical Director, Infection Prevention and Control, Mount Sinai Health System Learn more: http://newyork.metro.us/digital_launch.aspx?eid=88b69d63-31d0-4b30-ba33-aacc216b8671

New York Post – July 12 This Gadget Will Revolutionize the Way You Poop — Molly Shea In yoga groups and at brunch spots around the city, in-the-know New Yorkers can’t stop sharing their love for the Squatty Potty, a footstool that helps users squat while on the toilet, allowing for better bowel movements. “Physiologically, it’s better to poop at that angle,” said Gina Sam, MD, MPH, director of the Gastrointestinal Motility Center at The Mount Sinai Hospital. - Gina Sam, MD, MPH, Assistant Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Gastrointestinal Motility Center, The Mount Sinai Hospital Learn more: http://nypost.com/2016/07/12/this-gadget-will-revolutionize-the-way-you-poop/

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 12, 2016 Date: Tuesday, July 12, 2016 1:15:21 PM Attachments: ATT00002.txt

In the News July 12, 2016

The Washington Post – July 11 What Toxins Have You Been Exposed To? Your Baby Teeth May Hold The Answer. — Rachel Cernansky Baby teeth may soon be worth a lot more than the sentimental value they offer nostalgic parents. It turns out that these teeth store a unique type of health record, and they are the key to much of Manish Arora’s work. The director of exposure biology at the Icahn School of Medicine at Mount Sinai, Dr. Arora explains that teeth form rings as they grow— just as trees do, but daily instead of annually—and each ring contains information about exposures that occurred on the day it was formed. Dr. Arora will be using his tooth biomarker to study, among other things, how mixtures of chemicals affect neurodevelopment in children. - Manish Arora, BDS, MD, PhD, Associate Professor, Preventive Medicine, Assistant Professor, Dentistry, Director, Exposure Biology, Icahn School of Medicine at Mount Sinai Learn more: https://www.washingtonpost.com/national/health-science/what-toxins-have-you-been- exposed-to-your-baby-teeth-may-hold-the-answer/2016/07/11/9cf1d740-1d18-11e6-b6e0- c53b7ef63b45_story.html

Healio – July 11 Homebound Older Adults Face Increased Risk of Mortality — Chelsea Frajerman Pardes Homebound status was found to increased 2-year mortality, according to research presented at the annual American Geriatrics Society meeting. Tacara N. Soones, MD, an assistant professor of geriatrics and palliative medicine at the Icahn School of Medicine at Mount Sinai, and colleagues reported that the risk persisted after adjusting for several other factors. "There are approximately 2 million homebound older adults in the United States," Dr. Soones and colleagues wrote. "Although their multi-morbidity, disability and poor access to care would suggest an increased risk of death, the prognosis of homebound status is uncertain." - Tacara N. Soones, MD, Assistant Professor, Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai Learn more: http://www.healio.com/internal-medicine/geriatric-medicine/news/online/%7B89146e53- 8d50-47c6-98c3-67348eb1abe2%7D/homebound-older-adults-face-increased-risk-of-mortality

Healio’s Cardiology Today – July 11 Patients With HF After MI At Elevated Risk For Cancer — James Clark Patients who develop HF after MI face an increased risk for cancer, according to study data published in the Journal of the American College of Cardiology. In a related editorial, Jyoti Malhotra, MD, MPH, from Rutgers Cancer Institute, and Paolo Boffetta, MD, MPH, Chief of the Division of Cancer Prevention and Control at the Icahn School of Medicine at Mount Sinai, wrote that “... it is unlikely that HF is playing a causative role in carcinogenesis because cancer has a latent period of at least a few years. ... However, a role in the late stages of the carcinogenic process ... cannot be excluded.” - Paolo Boffetta, MD, MPH, Professor, Medicine, Hematology and Medical Oncology, Oncological Services, Preventive Medicine, Associate Director, Population Sciences, Tish Cancer Institute, Chief, Division of Cancer Prevention and Control, Icahn School of Medicine at Mount Sinai Learn more: http://www.healio.com/cardiology/hf-transplantation/news/online/%7B1a2f6deb-611b-4740- 9558-0a345559c630%7D/patients-with-hf-after-mi-at-elevated-risk-for-cancer Additional Coverage: Medpage Today: http://www.medpagetoday.com/cardiology/chf/59006

Healthcare Business Daily News – July 11 Massive New $175 Million Outpatient Center Opens at Mt. Sinai Queens — John Mitchell In announcing the opening of a six story, $175 million Queens outpatient campus, Mount Sinai joins a growing number of health systems across the country reinventing the delivery of health care services sparked under the Affordable Care Act. “We are transforming ourselves into a population health management organization focusing on wellness,” said Brian Radbill, MD, chief medical officer for Mount Sinai Queens. “Inpatient admissions are now considered a failure, which is largely what health care reform is about.” - Brian Radbill, MD, FACP, Associate Professor, Medicine, Nephrology, Icahn School of Medicine at Mount Sinai, Chief Medical Officer, Vice President of Medical Affairs, Mount Sinai Queens Learn more: https://www.dotmed.com/news/story/31873

The New York Times – July 12 Designing an Active, Healthier City — Meera Senthilingam Despite a firm reputation for being walkers, New Yorkers have an obesity epidemic on their hands. Mass urbanization has caused populations the world over to reduce the amount of time they spend moving their bodies. Safety, graffiti, proximity to a park, and even the appeal of stairwells, all play roles in whether someone chooses to be active or not. “There are bike rentals all throughout New York City, but they haven’t come up north to East Harlem,” said Carol Horowitz, MD, MPH, an associate professor of health policy and medicine at the Mount Sinai School of Medicine, who is trying to stem a high incidence of overweight and severe diabetes among her patients in Harlem. ”There’s malls people can walk in — they’re not in East Harlem.” - Carol Horowitz, MD, MPH, Associate Professor, Population Health Science and Policy, Medicine, General Internal Medicine, Icahn School of Medicine at Mount Sinai Learn more: http://www.nytimes.com/2016/07/12/opinion/designing-an-active-healthier-city.html?_r=0

New York Post – July 12 No One Knows Why More Adults Are Getting This Kids’ Disease — Molly Shea Type 1diabetes is an autoimmune disease in which the body stops producing insulin, which means it can’t break down sugar to use as energy. Up until the last decade, it was referred to as juvenile-onset diabetes — but it’s increasingly afflicting adults, according to the Juvenile Diabetes Research Foundation. “The number [of diagnoses] has been rising steadily over the last 20 years, but no one knows exactly why,” says Ronald Tamler, MD, medical director at the Mount Sinai Clinical Diabetes Institute. "The good news is that patients diagnosed with Type 1 Diabetes are living longer than ever.” - Ronald Tamler, MD, Associate Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Clinical Diabetes Institute Learn more: http://nypost.com/2016/07/12/no-one-knows-why-more-adults-are-getting-this-kids- disease/

Huffington Post – July 11 Minimizing Your Risk of Melanoma—the Deadliest Form of Skin Cancer — Hooman Khorasani, MD Melanoma incidence rates among Americans are increasing rapidly, in part due to our love of the outdoors and tanning, whether on a beach or in a booth. Melanoma originates in cells called melanocytes, which protect our skin against the sun’s harmful UV rays. It results from cellular gene changes that can be inherited and/or caused by UV radiation. The one risk factor you can control is exposure to UV radiation, writes Hooman Khorasani, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai. - Hooman Khorasani, MD, Assistant Clinical Professor, Dermatology, Chief, Division of Mohs, Reconstructive and Cosmetic Surgery, Icahn School of Medicine at Mount Sinai Learn more: http://www.huffingtonpost.com/mount-sinai-health-system/minimizing-your-risk-of- m_b_10927390.html

New York Post – July 12 Beware—Not All Sunscreen Is Created Equal — Christian Gollayan Many popular sunscreens don’t measure up to safety guidelines. A new study published in the American Medical Association’s JAMA Dermatology found that 40 percent of the top-selling sunscreens sold by Amazon.com didn’t meet recommendations set by the American Academy of Dermatology. Joshua Zeichner, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai, discusses four ways to make sure sunscreen is being used to the greatest effect. - Joshua Zeichner, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director, Cosmetic and Clinical Research in Dermatology, The Mount Sinai Hospital Learn more: http://nypost.com/2016/07/12/beware-not-all-sunscreen-is-created-equal/

Yahoo! Beauty – July 11 Blogger Shamed on Social Media While Recovering From Breast Reduction Surgery — Jenna Birch What’s a “normal” reaction following breast reduction surgery? It varies, according to C. Andrew Salzberg, MD, an associate professor of plastic surgery at the Icahn School of Medicine at Mount Sinai. “Most do it to relieve discomfort and almost all say they feel significantly better,” he tells Yahoo Beauty. “Even in the recovery room, they say they feel like a weight has been lifted.” Dr. Salzberg says it is not uncommon for a woman to get emotional prior to surgery. It’s also a bit of a journey back to full strength. - C. Andrew Salzberg, MD, Assistant Professor, Surgery, Plastic Surgery, Icahn School of Medicine at Mount Sinai Learn more: https://www.yahoo.com/beauty/16-year-old-is-shamed-on-1469858774335542.html

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 11, 2016 Date: Monday, July 11, 2016 11:34:31 AM Attachments: ATT00002.txt

In the News July 11, 2016

Healio’s Gastroenterology – July 8 Swallowed Flonase Effective For Long-term Maintenance in Pediatric EoE — Adam Leitenberger Long-term use of swallowed Flonase safely maintained endoscopic and clinical improvements and reductions in esophageal eosinophils among children with eosinophilic esophagitis, according to the results of an open-label, prospective, single-center study. “Topical corticosteroids in the form of fluticasone propionate to swallow or oral viscous budesonide have been shown to be effective in children ... but their efficacy or safety for chronic use has not yet been established,” wrote researchers from the Icahn School of Medicine at Mount Sinai. - Icahn School of Medicine at Mount Sinai Learn more: http://www.healio.com/gastroenterology/esophagus/news/online/%7B00fe7b90-5a03-49da- bd10-982466b79f5e%7D/swallowed-flonase-effective-for-long-term-maintenance-in-pediatric-eoe

Modern Healthcare – July 8 Do Patients Really Need Abbott's New Absorbable Stent? — Adam Rubenfire Abbot Vascular is touting a first-of-its-kind, fully dissolving artery stent, but some physicians wonder whether it's an improvement over existing treatments. Roxana Mehran, MD, a professor of cardiology at the Icahn School of Medicine at Mount Sinai, said that the new device presents an option for patients who don't want to have a foreign body in their arteries forever. Mount Sinai participated in trials for the stent. “Most patients would not like to have a foreign body in their arteries,” Dr. Mehran said, while noting that existing metallic stents are very effective. She said it'll be up to physicians to choose what's best for their patients. - Roxana Mehran, MD, Professor, Medicine, Cardiology, Population Science and Health Policy, Director, Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai Learn more: http://www.modernhealthcare.com/article/20160708/NEWS/160709954

Prevention – July 8 5 Most Common Types of Cancer In Women — Hallie Levine You may be surprised to learn that colon cancer is an equal opportunity offender, as the same number of women and men develop it each year, according to the American Cancer Society. "The good news is that it's almost entirely preventable," says David Greenwald, MD, director of clinical gastroenterology and endoscopy at The Mount Sinai Hospital. "[Colonoscopy] not only diagnoses colon cancer, it also allows your doctor to detect and remove polyps before they could become cancerous.” - David Greenwald, MD, Senior Faculty, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Clinical Gastroenterology, Endoscopy, The Mount Sinai Hospital Learn more: http://www.prevention.com/health/5-most-common-types-of-cancer-in-women

The Huffington Post – July 8 Craft Beer Isn’t As Healthy As It Sounds, But There’s Still Some Good News — Erin Schumaker Craft beer often features funky labels, but while it might look healthier than mass-produced brews, the real way to select the healthiest option is by taking stock of what’s inside the can. Average alcohol volume (ABV) is the most important factor to look for because beers with higher ABVs are typically higher in calories, Kelly Hogan, MS, RD, a clinical nutrition coordinator at the Dubin Breast Center of the Tisch Cancer Institute of Mount Sinai, said. “Every gram of alcohol contains about 7 calories,” Hogan explained. “The more alcohol in a beer, the more calories it will likely contain.” - Kelly Hogan, MS, RD, CDN, Clinical Nutrition Coordinator, The Dubin Breast Cancer of the Tisch Cancer Institute at Mount Sinai Learn more: http://www.huffingtonpost.com/entry/is-craft-beer-healthy_us_577e5d5ce4b0344d514e10c3

Self – July 8 Is Coconut Oil the Best Makeup Remover for Your Skin? — Korin Miller Does coconut oil work as a makeup remover that is also good for your skin? Maybe, says Gary Goldenberg, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai. “Makeup remover, like many skincare products, differs based on the specific type and specific ingredients,” said Dr. Goldenberg, adding that some products may contain alcohol or oil, while others are alcohol- and oil-free. - Gary Goldenberg, MD, Assistant Professor, Dermatology, Pathology, Icahn School of Medicine at Mount Sinai, Director, Dermatology Faculty Practice, The Mount Sinai Hospital Learn more: http://www.self.com/trending/2016/07/chrissy-teigen-swears-this-makeup-remover-is-best- for-her-skin/

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 8, 2016 Date: Friday, July 08, 2016 12:08:44 PM Attachments: ATT00002.txt

In the News July 8, 2016

Reuter’s Health – July 5 Statin Use Tied To Lower Risk of Inflammatory Bowel Disease — Marilynn Larkin Statin use is associated with a lower risk of developing inflammatory bowel disease (IBD), especially Crohn's disease in older patients, new research suggests. "Prior studies have suggested that statins can decrease inflammation and may improve IBD in patients who already have the disease. To our knowledge, this is the first study to show that statin exposure in patients without IBD is associated with a decreased risk of developing Crohn's disease and ulcerative colitis," said Ryan Ungaro, MD, an assistant professor of gastroenterology at the Icahn School of Medicine at Mount Sinai. - Ryan Ungaro, MD, Assistant Professor, Gastroenterology, Icahn School of Medicine at Mount Sinai Learn more: http://www.consultant360.com/story/statin-use-tied-lower-risk-inflammatory-bowel- disease

Environmental Health News – July 6 Acetaminophen During Pregnancy Linked to Autism — Brian Bienkowski Boys exposed before birth to a popular pain reliever in many brands including Tylenol were more likely to have symptoms of autism during childhood, according to a new study of mothers and children in Spain. “This is a good, important study, but not a definitive one,” said Shanna Swan, MD, a professor of preventive medicine at the Icahn School of Medicine at Mount Sinai, who was not involved in the study. “There is gratuitous use [of acetaminophen], some unnecessary use. It is risky … I think we know enough to say that.” - Shanna Swan, MD, Professor, Preventive Medicine, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai Learn more: http://www.environmentalhealthnews.org/ehs/news/2016/july/acetaminophen-during- pregnancy-linked-to-autism

Bel Marra Health – July 6 Crohn’s Disease Associated With A Higher Cancer Risk Than Ulcerative Colitis: Study — Devon Andre The findings of a Denmark-based study revealed that patients with Crohn’s disease have a greater overall risk for colon cancer compared to the general public, but the same was not true for those with ulcerative colitis. It is well documented that Crohn’s disease patients face a higher risk of colon cancer. Thomas Ullman, MD, an associate professor of gastroenterology at the Icahn School of Medicine at Mount Sinai, explained, “In up to half of Crohn’s disease patients, some or all of the colon is involved. The more colon that’s involved, the greater the risk. And the longer the patient has had chronic inflammation of the colon, the greater the risk as well.” - Thomas Ullman, MD, Associate Professor, Medicine, Gastroenterology, Senior Associate Dean, Clinical Affairs, Icahn School of Medicine at Mount Sinai Learn more: http://www.belmarrahealth.com/crohns-disease-associated-with-a-higher-cancer-risk-than- ulcerative-colitis-study/

New York Daily News – July 7 HIV-Positive Kidney Donors Are Helping to Save More Lives — Sander S. Florman, MD More than 90,000 Americans are currently on the United Network for Organ Sharing (UNOS) waiting list for a kidney transplant, and there aren't nearly enough donor organs to go around. It is estimated that there could be as many as 2,000 HIV-positive donors in the United States — donors whose organs previously were not pursued because it was illegal. Now, thanks to the passing of the Hope Act, many of these donors will be able to donate and save lives. We expect that this change in policy will bring about the largest increase to the pool of donor organs in the past 20 years, writes Sander Florman, MD, director of the Recanati/Miller Transplant Institute at Mount Sinai. - Sander Florman, MD, Professor, Surgery, Icahn School of Medicine at Mount Sinai, Director, Recanati/Miller Transplant Institute Learn more: http://www.nydailynews.com/life-style/hiv-positive-kidney-donors-helping-save-lives- article-1.2703166

Refinery 29 – July 7 Here's Why The FDA Thinks Cryotherapy Is A Terrible Idea — Taylor Bryant A recent FDA report declared that the supposed health benefits of whole-body cryotherapy (WBC) are pretty much BS. "What's happening [with WBC] is you're activating your fight-or-flight response, which gives you an adrenaline rush," says Houman Danesh, MD, the director of integrative pain management at The Mount Sinai Hospital. "It makes you feel awake, and most people claim they feel great when they walk out because they activated that system. But sitting in an ice bath would have the same benefits. It's just not as comfortable." Joshua Zeichner, MD, an assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai, uses localized cryotherapy to remove precancerous sun spots and warts with liquid nitrogen, but he also echoes the FDA's statements on WBC. "While full-body cryotherapy has gained much media attention, there is little data showing that it is truly effective in treating medical conditions or aging skin," he says. - Houman Danesh, MD, Assistant Professor, Anesthesiology, Rehabilitative Medicine, Icahn School of Medicine, Director, Division of Integrative Pain Management, The Mount Sinai Hospital - Joshua Zeichner, MD, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director, Cosmetic and Clinical Research in Dermatology, The Mount Sinai Hospital Learn more: http://www.refinery29.com/2016/07/115994/cryotherapy-fda-report

Consumer Reports – July 7 How to Treat a Burn From Grilling and Cooking — Hallie Levine While some home cures for burns, like aloe vera, are effective, others can make the burn worse. Some people think the protein in milk promotes healing, that's untrue, says Gary Goldenberg, MD, an assistant clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai. In addition, the bacteria in the milk could multiply and trigger a skin infection. - Gary Goldenberg, MD, Assistant Professor, Dermatology, Pathology, Icahn School of Medicine at Mount Sinai, Director, Dermatology Faculty Practice, The Mount Sinai Hospital Learn more: http://www.consumerreports.org/conditions-treatments/how-to-treat-a-burn/

Yahoo! Style – July 7 How Safe and Effective Are Waist Trainers? — Jenna Birch Waist trainers are seemingly always in the news for some reason, whether positive or negative, but how safe and effective are they? “They’re similar to a corset, where they restrict the waist,” says Gina Sam, MD, MPH, director of the Gastrointestinal Motility Center at The Mount Sinai Hospital. She explained that most women “do just fine” with a little extra support around the middle. “Some claim you will lose body fat while using a waist trainer, and that is not true. There is no research to support that.” - Gina Sam, MD, MPH, Assistant Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Gastrointestinal Motility Center, The Mount Sinai Hospital Learn more: https://www.yahoo.com/style/chrissy-teigen-admits-to-using-1467132396675126.html

The Wall Street Journal – July 7 Matt Harvey Weighs Season-Ending Surgery — Andrew Beaton Matt Harvey, the Mets’ struggling ace suffering through a career-worst season, may be done for 2016. The team said on Thursday that the 27-year-old Harvey has “symptoms consistent” with thoracic outlet syndrome. There are several potential causes for thoracic outlet syndrome, or TOS, said James Gladstone, MD, co-chief of the sports medicine service at The Mount Sinai Hospital. Among them are scar tissue that can develop from repetitive overuse—the type pitchers can experience when they’re “microscopically tearing those areas repeatedly.” - James Gladstone, MD, Associate Professor, Orthopaedics, Sports Medicine Service, Icahn School of Medicine at Mount Sinai, Co-Chief, Sports Medicine, The Mount Sinai Hospital Learn more: http://www.wsj.com/articles/matt-harvey-weighs-season-ending-surgery-1467928406 Additional Coverage: New York Post: http://nypost.com/2016/07/07/matt-harvey-faces-call-on-season-ending-surgery/ NJ.com: http://www.nj.com/mets/index.ssf/2016/07/whats_thoracic_outlet_syndrome_medical_expert_expl.html

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 7, 2016 Date: Thursday, July 07, 2016 11:13:25 AM Attachments: ATT00004.txt

In the News July 7, 2016

Modern Healthcare – July 7 Emergency Department Mortality Rates Plummet Over 15 Years — Erica Teichert Emergency departments across the country saw a nearly 50% drop in adult deaths over a 15-year period, according to a new study published in Health Affairs. Although the study couldn't pinpoint an exact cause for the changes in ED mortality rates from 1997 to 2011, the authors noted that changes in pre- hospital, emergency and palliative care could all be factors. Marc Probst, MD, an assistant professor of emergency medicine at the Icahn School of Medicine at Mount Sinai and co-author of the study said, “I think it's something as a healthcare system that we're working on in making the final experience as painless as possible not just for the patient but for the family.” - Marc Probst, MD, MS, Assistant Professor, Emergency Medicine, Icahn School Of Medicine at Mount Sinai Learn more: http://www.ozy.com/fast-forward/can-trauma-be-passed-from-parent-to-child/70261

OZY – July 7 Can Trauma Be Passed From Parent to Child? — Rignam Wangkhang Recent studies on the science behind intergenerational trauma — between Holocaust survivors and their children, for instance — have discovered that trauma can be passed between generations. A research team led by Rachel Yehuda, PhD, director of the Traumatic Stress Studies Division at the Icahn School of Medicine at Mount Sinai, concluded that some of these tags could be transferred across generations. When Dr. Yehuda researched mothers who were pregnant and in the World Trade Center during 9/11, she discovered that environmental fallout could even leave an imprint in utero. “The idea that we can be transformed by our environment gives us powerful tools for resilience building,” says Dr. Yehuda. The plasticity of genes points toward the possibility of future transformation. - Rachel Yehuda, PhD, Professor, Psychiatry, Neuroscience, Director, Traumatic Stress Studies Division, Icahn School of Medicine at Mount Sinai Learn more: http://www.ozy.com/fast-forward/can-trauma-be-passed-from-parent-to-child/70261

HealthDay News – July 6 Gene Test Might One Day Gauge Alzheimer's Risk in Younger Adults — Steven Reinberg A gene test may one day be able to predict the risk for Alzheimer's disease in young adults, a new study suggests. But Sam Gandy, MD, PhD, director of the Center for Cognitive Health at The Mount Sinai Hospital, said people should not be rushing out to get tested to see if they have a high risk of Alzheimer's. "It's only for research at this point," he said. "It's potentially very useful in designing super early interventions, but not clinically useful yet." - Samuel Gandy, MD, PhD, Professor, Neurology, Psychiatry, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Center for Cognitive Health Learn more: https://consumer.healthday.com/cognitive-health-information-26/alzheimer-s-news- 20/gene-test-might-one-day-gauge-alzheimer-s-risk-in-young-adults-712654.html Additional Coverage: WebMD: http://www.webmd.com/alzheimers/news/20160706/gene-test-might-one-day-gauge- alzheimers-risk-in-younger-adults Tech Times: http://www.techtimes.com/articles/168757/20160707/new-gene-test-may-spot-alzheimers- disease-risk-at-age-35.htm

Medpage Today – July 7 Absorb Stent Approval: Who's Actually Going to Get it? — Nicole Lou While cheering FDA approval of the Absorb bioabsorbable stent, many cardiovascular interventionalists anticipate using it in only a minority of their patients as they wait for more data and advancing technology. Annapoorna S. Kini, MD, director of the cardiac catheterization laboratory at The Mount Sinai Hospital, emphasized techniques to make sure the bioabsorbable stent is expanded. The three steps of pre-dilatation, scaffold placement, and post-dilatation can reduce the risk of scaffold thrombosis to that of "any other stent," she suggested. - Annapoorna Kini, MBBS, Professor, Medicine, Cardiology, Icahn School of Medicine at Mount Sinai, Director, Cardiac Catheterization Laboratory, The Mount Sinai Hospital Learn more: http://www.medpagetoday.com/Cardiology/PCI/58928

HealthDay News – July 7 U.S. Teens Less Sweet on Soft Drinks — Dennis Thompson American teens are turning their backs on soft drinks, says a new government survey that shows soda consumption among youth declined by almost a third in just two years. Among other changes in policy, the banning of sugary sodas from vending machines has also played a large role in reducing soft drink consumption, said Ronald Tamler, MD, medical director at the Mount Sinai Clinical Diabetes Institute. "If you go to The Mount Sinai Hospital, you literally cannot get a sugar-sweetened soda from the vending machine," Dr. Tamler said. "Increasingly, there are schools that have the same model, so children find it more difficult to get sodas." - Ronald Tamler, MD, Associate Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Clinical Diabetes Institute Learn more: https://consumer.healthday.com/diabetes-information-10/sugar-health-news-644/teens- turning-down-soft-drinks-712485.html

Medscape – July 6 At Last, Progress in Managing Social Dysfunction in Mental Illness — Bret Stetka After her presentation at the American Psychiatric Association's 2016 Annual in Atlanta, Georgia, Mercedes Perez-Rodriguez, MD, PhD, assistant professor of psychiatry at the Icahn School of Medicine at Mount Sinai, spoke with Medscape about the idea of "social cognition" and how one therapy shows promise in treating the impaired social processing that comes with certain mental illnesses. - Maria de las Mercedes Perez-Rodriguez, MD, PhD, Assistant Professor, Psychiatry, Icahn School of Medicine at Mount Sinai Learn more: http://www.medscape.com/viewarticle/865559

NBC News – July 7 White House to Take Action on Opioid Abuse Epidemic by Asking for Funding The Obama administration announced it is loosening restrictions on a drug used to ease opioid addicts' cravings. The drug, called Buprenorphine, has been tightly controlled because it's also an opioid, but the effects are milder and are less likely to lead to overdoses. Right now doctors authorized to prescribe buprenorphine have a cap of 100 patients. Starting august 5th that number will nearly triple to 275 patients. "You're not giving another medication for the addiction. You're giving the medication to stabilize the person so they can work their recovery," said Richard Rosenthal, MD, medical director of Addiction Psychiatry for the Mount Sinai Behavioral Health System. - Richard Rosenthal, MD, Professor, Psychiatry, Icahn School of Medicine at Mount Sinai, Medical Director, Addition Psychiatry, Mount Sinai Behavioral Health System Learn more: http://www.kristv.com/story/32389931/white-house-takes-on-opioid-epidemic

Hindustan Times – July 7 Breakthrough Hepatitis C Treatment Set to Enter India Soon Gilead Sciences, together with its 11 partners in India, are pioneering a voluntary licensing model that transfers technology and Intellectual Property for latest treatment sand cures for viral Hepatitis and HIV. A drug called Epclusa, which treats all genotypes of the Hepatitis C virus developed by Gilead Sciences, was last week approved by the US Food and Drug Administration. “The approval of Epclusa represents an important step forward in the global effort to control and potentially eliminate HCV as it provides a safe, simple and effective cure,” said Ira Jacobson, MD, chair of the Department of Medicine at Mount Sinai Beth Israel. - Ira Jacobson, MD, Chair, Department of Medicine, Mount Sinai Beth Israel Learn more: http://www.hindustantimes.com/business-newspaper/breakthrough-hepatitis-c-treatment- set-to-enter-india-soon/story-12F7fpZgrOaWQridr59xhO.html

Furthermore – July 6 Why Do You Sweat the Bed? — Virginia Pelley Body temperature naturally drops during sleep; however, many people perspire at night, and sometimes excessively. It could be due to a lot of things, but the culprit is often simply an overheated bedroom or sleeping with too many bedcovers, says Deena Adimoolam, MD, an assistant professor of endocrinology at the Icahn School of Medicine at Mount Sinai. - Deena Adimoolam, MD, Assistant Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai Learn more: http://furthermore.equinox.com/articles/2016/07/causes-of-night-sweats

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 6, 2016 Date: Wednesday, July 06, 2016 3:22:05 PM Attachments: ATT00002.txt

In the News July 6, 2016

Crain’s New York – July 6 Drug Companies Are Breaking Social Contract, Says Mount Sinai CEO New York and some other states are starting to offer Medicaid coverage for expensive hepatitis C drugs, which range from around $50,000 to $90,000 for a 12-week course of treatment. By charging prohibitive specialty-drug prices that exceed what’s needed for a return on their investments, drug companies have broken their social contract with patients and taxpayers, said Kenneth L. Davis, MD, President and CEO of the Mount Sinai Health System, during a recent panel on drug spending at the 2016 Aspen Ideas Festival. A Pfizer representative on the panel argued that the hepatitis C drugs produced by Gilead Sciences are cost-effective despite their high prices because of the health care benefits and savings they generate in the long term. But Dr. Davis argued that if the polio vaccine had been priced based its future cost-effectiveness, he might never have received it as a child. Dr. Davis did offer some pragmatic suggestions, such as raising drug prices in other countries where they are lower than in the U.S., “in order that American citizens don't have to pay the whole cost of R&D.” - Kenneth L. Davis, MD, President, Chief Executive Officer, Mount Sinai Health System Learn more: http://www.crainsnewyork.com/article/20160706/PULSE/160709986/catholic-charities-sheds- programs-for-people-with-developmental

Parent Herald – July 5 Bullying Feels Rewarding Because It Activates The Brain's Reward System — Elizabeth Anderson Researchers at the Icahn School of Medicine at Mount Sinai have found that bullying triggers the brain's reward system, causing bullies to feel that their behavior is rewarding. The researchers' study was published in Nature. "Our study is the first to demonstrate that bullying behavior activates a primary brain reward circuit that makes it pleasurable to a subset of individuals. Furthermore, we show that manipulating activity in this circuit alters the activity of brain cells and ultimately, aggression behavior," said Scott Russo, PhD, an associate professor of neuroscience at the Icahn School of Medicine at Mount Sinai. - Scott Russo, PhD, Associate Professor, Neuroscience, Icahn School of Medicine at Mount Sinai Learn more: http://www.parentherald.com/articles/52872/20160705/bullying-feels-rewarding-activates- brains-reward-system.htm

WABC 7 – July 5 New Vaccine Uses Body's Immune System To Fight Lymphomas — Denise Dador Lymphomas are the fifth most common type of cancer in the U.S., and certain forms of the disease may be very resistant to treatment and difficult to cure. Researchers at the Icahn School of Medicine at Mount Sinai are testing a vaccine that harnesses the body's immune system to fight back, and, in some cases, it has even put patients into remission. "The real purpose of this is to make the tumors everywhere in the body melt away," said Joshua Brody, MD, director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai. Dr. Brody said health professionals hope the vaccine, much like ones used to protect against chicken pox or other diseases, will work to keep the cancer at bay for many years. - Joshua Brody, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Director, Lymphoma Immunotherapy Program, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai Learn more: http://abc7.com/health/new-vaccine-uses-bodys-immune-system-to-fight- lymphomas/1414874/

Medpage Today – July 5 Yearly Lung CT OK for Patients With Nonsolid Nodules — Salynn Boyles Yearly low-dose computed tomography (CT) appears to be an effective surveillance strategy for long- time current or former smokers with nonsolid nodules identified through initial CT screening, according to an analysis of data from the National Lung Cancer Screening Trial (NLST). "This report adds further support toward taking a conservative approach for annual follow-up for the management and treatment of nonsolid nodules, especially when they are solitary," wrote researcher Claudia Henschke, MD, a clinical professor of radiology at the Icahn School of Medicine at Mount Sinai, and colleagues. - Claudia Henschke, MD, Clinical Professor, Radiology, Icahn School of Medicine at Mount Sinai, Chief, Lung and Cardiac Screening Program, The Mount Sinai Hospital Learn more: http://www.medpagetoday.com/hematologyoncology/lungcancer/58889 Additional Coverage: Science Daily: https://www.sciencedaily.com/releases/2016/07/160705085717.htm

Modern Healthcare – July 5 Abbott Gains Approval For First Fully Dissolving Artery Stent — Adam Rubenfire The Food and Drug Administration has approved the first fully absorbable stent used to treat coronary artery disease. The recent advance shouldn't put a damper on the success of metallic stents, which have come a long way in the last decade, said Roxana Mehran, MD, a professor of cardiology at the Icahn School of Medicine at Mount Sinai. “Most patients would not like to have a foreign body in their arteries,” Dr. Mehran said. “We have to make sure that we're careful that we don't bash all of the work done to date. The metallic stents are incredibly effective.” - Roxana Mehran, MD, Professor, Medicine, Cardiology, Population Science and Health Policy, Director, Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai Learn more: http://www.modernhealthcare.com/article/20160705/NEWS/160709983/abbott-gains- approval-for-first-fully-dissolving-artery-stent

Healthcare Business Daily News – July 5 Analysis Shows Most Patients Undergoing Robotic Surgery Are Rich White Men — Lauren Dubinsky Wealthy, white men are the most likely candidates for robotic surgery and minorities, women and those with lower incomes are left with fewer surgical options, according to an analysis from Mount Sinai Beth Israel Hospital. "The reasons behind this phenomenon are multi-factorial," said Mark Finkelstein, MD, a research assistant at Icahn School of Medicine at Mount Sinai. "Certainly limitations in access to surgeons that provide robotic assisted care seem to play a role." - Mark Finkelstein, MD, Research Assistant, Icahn School of Medicine at Mount Sinai Learn more: https://www.dotmed.com/news/story/31787

HealthDay News – July 6 Doctor-Assisted Deaths Didn't Soar After Legalization — Steven Reinberg Public support for physician-assisted death has plateaued in the United States, and the practice hasn't soared as some had feared, a new study finds. R. Sean Morrison, MD, co-director of the Patty and Jay Baker National Palliative Care Center at the Icahn School of Medicine at Mount Sinai, believes the debate on physician-assisted death is misplaced. "The continued focus on assisted suicide is distracting us from the opportunity to better enhance care of people with serious illness," said Dr. Morrison. "We know that palliative care reduces pain and emotional concerns. We know that it improves the quality of life for those who fear a tormented or distressing death." - R. Sean Morrison, MD, Professor, Geriatrics and Palliative Medicine, Anesthesiology, Medicine, Icahn School of Medicine at Mount Sinai, Co-Director, Patty and Jay Baker National Palliative Care Center, Director of the National Palliative Care Research Center, Director, Lilian and Benjamin Hertzberg Palliative Care Institute, The Mount Sinai Hospital Learn more: http://www.pantagraph.com/lifestyles/health-med-fit/doctor-assisted-deaths-didn-t-soar- after-legalization/article_1fdb8535-7c0d-5518-a610-04ceadca505f.html

TCT MD – July 5 Thin-Cap Fibroatheromas May Help Explain Poor PCI Outcomes in Diabetic Patients — Todd Neale After undergoing successful PCI, diabetic patients with ACS have a markedly higher risk of major adverse cardiac events—particularly those arising from nonculprit lesions—when at least one IVUS- identified thin-cap fibroatheroma (TCFA) is present, an analysis of the PROSPECT study shows. But among patients without this feature, outcomes are similar regardless of diabetes status. According to Pedro Moreno, MD, a professor of cardiology at the Icahn School of Medicine at Mount Sinai, who was not involved in the research, the study is an important addition to the literature on the controversial vulnerable plaque hypothesis—namely, that plaques most likely to rupture and cause events can be identified and potentially treated to prevent poor outcomes. - Pedro Moreno, MD, Professor, Medicine, Cardiology, Icahn School of Medicine at Mount Sinai Learn more: http://www.tctmd.com/show.aspx?id=135883

ABC News – July 5 How Music Therapy Can Lift Body and Soul for Patients — Julie Barzilay Music therapy can be used to regulate the heartbeat, improve mood, distract from or even delve into the emotions of being sick. Todd O’Connor, the senior creative arts therapy supervisor at the Kravis Children’s Hospital at Mount Sinai, said music therapy is about “being able to take something familiar like a piece of music and adapt it in the moment to what the conditions of the patient are in terms of their mood, their pain level, their need for sleep.” Jonathan Weiss, a creative arts therapist at Mount Sinai St. Luke’s, works primarily with child adolescent psychiatric inpatients. He noted that many of these children are grappling with traumatic pasts and that music can help patients process and communicate about trauma in a way that is nonthreatening. Joanne Loewy, DA, director of the Louis Armstrong Center for Music and Medicine at Mount Sinai Beth Israel, has been researching what she calls “songs of kin” — music with particular meaning to a patient or family, often across generations. - Joanne Loewy, DA, LCAT, MT-BC, Associate Clinical Professor, Family Medicine and Health, Icahn School of Medicine at Mount Sinai, Director, The Louis Armstrong Center for Music and Medicine at Mount Sinai Beth Israel - Todd O’Connor, Program Manager, Child Life Program, Senior Creative Arts Therapy Supervisor, Kravis Children’s Hospital at Mount Sinai - Jonathan Weiss, LCAT, Creative Arts Therapist, Mount Sinai St. Luke’s Learn more: http://abcnews.go.com/Health/music-therapy-lift-body-soul-patients/story?id=40279975 WCBS 2 – July 5 Experts: Protect Kids Against Dehydration During Summer Heat The first real heat wave of the summer may be coming, and that means remembering how to prevent heat-related problems. Shearer, the medical director at the Mount Sinai emergency room, said it is rare to see kids come in with a serious heat illness – because kids are pretty good at drinking fluids when they get thirsty. But it is still a good idea for parents to be vigilant. “They should be asking you every once in a while to go to the bathroom,” said Peter Shearer, MD, an assistant professor of emergency medicine at the Icahn School of Medicine at Mount Sanai. “They should be urinating throughout the course of the day.” - Peter Shearer, MD, Assistant Professor, Emergency Medicine, Icahn School of Medicine at Mount Sinai, Medical Director, Mount Sinai Emergency Department, The Mount Sinai Hospital Learn more: http://newyork.cbslocal.com/2016/07/05/kids-heat-wave-hydration/

Healthcare IT News – July 6 Mount Sinai Launches MountSinaiNY Mobile App to Give Patients Access to Epic EHR — Bernie Monegain Mount Sinai Health System has posted MountSinaiNY, a mobile application designed in-house and aimed at engaging patients by making it easier to find information and services the health system offers. “The MountSinaiNY app is a digital gateway to the many services we provide at Mount Sinai,” said Kumar Chatani, MBA, chief information officer of the Mount Sinai Health System. “We continue to use innovative technology to engage patients while streamlining their experience within our health system.” - Kumar Chatani, MBA, Executive Vice President, Chief Information Officer, Mount Sinai Health System Learn more: http://www.healthcareitnews.com/news/mount-sinai-launches-mtsinainy-mobile-app-give- patients-access-epic-ehr

MD Magazine – July 5 New Agents Provide More Hope for Multiple Sclerosis Care The past few years have seen the development and approval of a wide range of multiple sclerosis treatments. This has meant doctors have many more options when looking to help their patients. Stephen Krieger, MD, attending physician at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Mount Sinai Hospital, discussed some of these new treatment options during the American Academy of Neurology in Vancouver. It was not long ago that there were no treatments for patients, especially with the relapsing form, but that has changed drastically with more than a dozen medications to choose from and working being done to help those with progressive multiple sclerosis. - Stephen Krieger, MD, Associate Professor, Neurology, Icahn School of Medicine at Mount Sinai, Attending Physician, Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Mount Sinai Hospital Learn more: http://www.hcplive.com/medical-news/stephen-krieger-from-mount-sinai-hospital-new- agents-provide-more-hope-for-multiple-sclerosis-care

Chicago Tribune – July 5 Birth Control Options For Women Over 40—Other Than the Pill — Barbara Sadick Some doctors advise against women using birth control pills after age 40, but women need to protect themselves against unwanted pregnancy until one year after menopause, which on average occurs at the age of 51-52. Gillian Dean, MD, MPH an associate professor of obstetrics, gynecology and reproductive science at the Icahn School of Medicine at Mount Sinai, said women have more options than ever when reassessing their birth control choices. "The methods I discuss most are the most effective and easiest to use: the IUD and the implant. But if I have a healthy nonsmoking patient who wants to stay on pills, I counsel her that it's a safe and effective option all the way until menopause," she said. - Gillian Dean, MD, MPH, Associate Professor, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, Director, Fellowship in Family Planning Learn more: http://www.chicagotribune.com/lifestyles/health/sc-options-after-40-pill-health-0706- 20160705-story.html

Prevention – July 5 6 Secrets Of People Who Poop Perfectly — Hallie Levine There are some habits that will help anybody maintain a regular GI tract. Anything with sugar in it— soft drinks, juice, even Gatorade—can spell disaster for your GI tract. "The bad bacteria in your gut love to feed on sugar, which in turn slows it down," says Gina Sam, MD, MPH, director of the Gastrointestinal Motility Center at The Mount Sinai Hospital. - Gina Sam, MD, MPH, Assistant Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Gastrointestinal Motility Center, The Mount Sinai Hospital Learn more: http://www.prevention.com/health/6-secrets-of-people-who-poop-perfectly

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 5, 2016 Date: Tuesday, July 05, 2016 11:10:54 AM Attachments: ATT00002.txt

In the News July 5, 2016

Medical Xpress – July 5 CT Follow-Up Sufficient For Some Lung Nodules Annual low-dose computed-tomography (CT) screening can eliminate the need for biopsy or surgery in nonsolid lung nodules, according to a new study published online in the journal Radiology. "When you biopsy a nonsolid nodule, it's usually pre-malignant, noninvasive, or due to some other cause like infection or fibrosis," said study co-author Claudia Henschke, MD, a clinical professor of radiology at the Icahn School of Medicine at Mount Sinai. "We're hoping that by making screening more efficient we will convince CMS to slowly broaden the guidelines to include others at risk, including those exposed to secondhand smoke," said study lead author Rowena Yip, MPH, a senior biostatistician at the Icahn School of Medicine at Mount Sinai. - Claudia Henschke, MD, Clinical Professor, Radiology, Icahn School of Medicine at Mount Sinai, Chief, the Lung and Cardiac Screening Program, The Mount Sinai Hospital - Rowena Yip, MPH, Senior Biostatistician, Radiology, Icahn School of Medicine at Mount Sinai Learn more: http://medicalxpress.com/news/2016-07-ct-follow-up-sufficient-lung-nodules.html

NDTV – July 3 Bullies' Brains Wired To Get Pleasure From Aggression: Study The brains of bullies' are wired to seek pleasure from picking on victims, a new study in mice has found. Individual differences in the motivation to engage in or to avoid aggressive social interaction (bullying) are mediated by the basal forebrain, lateral habenula circuit in the brain, researchers said. "Our study is the first to demonstrate that bullying behavior activates a primary brain reward circuit that makes it pleasurable to a subset of individuals," said Scott Russo, PhD, an associate professor of neuroscience at the Icahn School of Medicine at Mount Sinai. "Furthermore, we show that manipulating activity in this circuit alters the activity of brain cells and ultimately, aggression behavior.” - Scott Russo, PhD, Associate Professor, Neuroscience, Icahn School of Medicine at Mount Sinai Learn more: http://www.ndtv.com/health/bullies-brains-wired-to-get-pleasure-from-aggression-study- 1427448

Health Payer Intelligence – July 5 Why HEDIS Quality Measures Matter for Value-Based Care — Vera Gruessner The Healthcare Effectiveness Data and Information Set (HEDIS) is used by more than 90 percent of health payers to assess and collect data on the performance of providers. As value-based care reimbursement protocols continue to become a mainstay in the healthcare industry, more payers are bringing HEDIS measures to the forefront. For example, the commercial health payer Humana has partnered with Mount Sinai Health Partners to ensure Medicare Advantage beneficiaries obtain greater healthcare access to Mount Sinai’s hospitals and physician practices. “When physicians, health systems, and health plans work together to align efforts and incentives, patient outcomes improve,” said Niyum Gandhi, chief population health officer for the Mount Sinai Health System. - Niyum Gandhi, Executive Vice President, Chief Population Health Officer, Mount Sinai Health System Learn more: http://healthpayerintelligence.com/news/why-hedis-quality-measures-matter-for-value- based-care

Pharma Exec – June 29 Patient Centricity is So Much More than a Customer Satisfaction Survey — Pam Garfield With something as personal and significant as an individual’s health, it’s important to dig deeper than just asking how they feel about the experience itself. This sells the patient centricity movement short. Patients have so much more to contribute; they can actually improve trial design and outcomes. Matthew Galsky, MD, director of genitourinary medical oncology at the Icahn School of Medicine at Mount Sinai, was quoted in the Wall Street Journal saying, "Perhaps the questions we are asking [in testing new treatments] are not the questions that are important to patients.” - Matthew Galsky, MD, Associate Professor, Medicine, Hematology and Medical Oncology; Assistant Professor, Urology; Director, Genitourinary Medical Oncology, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai Learn more: http://www.pharmexec.com/have-we-met-your-needs-today-patient-centricity-so-much- more-customer-satisfaction-survey

Becker’s Spine Review – June 30 Mount Sinai Spine Center Names Dr. Sheeraz Qureshi Associate Director — Megan Wood The Mount Sinai Hospital's spine center named Sheeraz Qureshi, MD, associate director. Additionally, Dr. Qureshi will serve as chief of minimally invasive spine surgery at the Icahn School of Medicine at Mount Sinai. He specializes in minimally invasive and motion-sparing spine surgery, with an emphasis on cervical and lumbar spine surgery. - Sheeraz Qureshi, MD, Associate Professor, Orthopaedics, Icahn School of Medicine at Mount Sinai, Associate Director, Mount Sinai Spine Center, Chief, Minimally Invasive Spine Surgery, Icahn School of Medicine at Mount Sinai Learn more: http://www.beckersspine.com/spine/item/32092-mount-sinai-spine-center-names-dr- sheeraz-qureshi-associate-director-5-highlights.html

Health – July 1 Is Wash-On Sunscreen the Lazy Person's Answer to Skin Protection? — Jenna Birch Beauty bloggers have been abuzz in the last year over a technology that promises to make SPF application faster and easier: wash-on sunscreen. “Although the technology sounds interesting and advanced, I would still recommend a sunscreen lotion or cream,” says Gary Goldenberg, MD, an assistant clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai. User error is the main concern. “Theoretically, the technology works, but the trick is letting the product sit long enough on your face for it to be absorbed,” - Gary Goldenberg, MD, Assistant Professor, Dermatology, Pathology, Icahn School of Medicine at Mount Sinai, Director, Dermatology Faculty Practice, The Mount Sinai Hospital Learn more: http://www.health.com/beauty/sunscreen-face-wash

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200

From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - July 1, 2016 Date: Friday, July 01, 2016 12:03:35 PM Attachments: ATT00002.txt

In the News July 1, 2016

MPR News – June 28 Aspen Ideas Festival: Cancer Breakthroughs In advance of Vice President Biden's "National Cancer Moon Shot Summit,” four top cancer researchers gathered to talk about the latest breakthroughs and the potential for treatments and cures. Through research, clinical trials, and outreach, they are trying to get the immune system to fight cancer and develop a new class of personalized drugs. Gathered for a panel at the Aspen Ideas Festival to discuss cancer breakthroughs were Joshua Brody, MD, director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai; Steven Burakoff, MD, Director of The Tisch Cancer Institute at Mount Sinai; Ross Cagan, PhD, professor of developmental and regenerative biology and oncological sciences at the Icahn School of Medicine at Mount Sinai; and Matthew Galsky, MD, director of genitourinary medical oncology at the Icahn School of Medicine at Mount Sinai. Kenneth L. Davis, MD, President and CEO of the Mount Sinai Health System, moderated the discussion. - Kenneth L. Davis, MD, President, Chief Executive Officer, Mount Sinai Health System - Joshua Brody, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Director, Lymphoma Immunotherapy Program, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai - Steven Burakoff, MD, Professor, Oncological Science, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Director, The Tisch Cancer Institute at Mount Sinai - Ross Cagan, PhD, Professor, Developmental and Regenerative Biology, Oncological Sciences, Ophthalmology, Senior Associate Dean for the Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai - Matthew Galsky, MD, Associate Professor, Medicine, Hematology and Medical Oncology; Assistant Professor, Urology; Director, Genitourinary Medical Oncology, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai Learn more: http://www.mprnews.org/story/2016/06/28/mpr_news_presents

Healthcare Business Daily News – June 30 Mount Sinai Health System Launches Mobile Application For Patients Mount Sinai Health System announced the launch of a new mobile application for patients called MountSinaiNY. “The MountSinaiNY app is a digital gateway to the many services we provide at Mount Sinai,” said Kumar Chatani, MBA, chief information officer of the Mount Sinai Health System. “We are developing innovative, user-friendly platforms to give our patients access to all our health system has to offer,” said Sandra Myerson, MBA, RN, senior vice president and chief patient experience officer at the Mount Sinai Health System. “The MountSinaiNY app will connect patients with our renowned physicians while enabling them to seamlessly manage key business matters.” - Kumar Chatani, MBA, Executive Vice President, Chief Information Officer, Mount Sinai Health System - Sandra Myerson, MBA, MS, BSN, RN, Senior Vice President, Chief Patient Experience Officer, The Joseph F. Cullman, Jr. Institute for Patient Experience at The Mount Sinai Hospital Learn more: https://www.dotmed.com/news/story/31735

Lifezette – June 30 Reducing Risks of Endometrial Cancer — Kristen Fischer Women with BRCA1 gene mutations face many decisions upon finding out they have this heightened risk factor for breast and ovarian cancer. One option to lower their risk is surgery, but a new study shows that only removing ovaries and fallopian tubes may not be enough—a hysterectomy could be more effective at cutting their chances of developing the disease. Konstantin Zakashansky, MD, an associate professor of obstetrics and gynecology at the Icahn School of Medicine at Mount Sinai, said women undergoing ovarian removal should "definitely consider" a prophylactic hysterectomy at the same time to lower their uterine cancer risk. "In a majority of cases, it should not pose significant additional risk to the surgery and can be performed using a minimally invasive approach," Dr. Zakashansky said. - Konstantin Zakashansky, MD, Associate Professor, Obstetrics, Gynecology, Reproductive Science, Icahn School of Medicine at Mount Sinai Learn more: http://www.lifezette.com/healthzette/reducing-risks-of-endometrial-cancer/

New York Daily News – June 30 Get Out of Hair! Most American Women Like to Go Bare Down There — Nicole Lyn Pesce A hair-raising new JAMA Dermatology report released this week surveyed 3,316 ladies and found that completely removing pubic hair was the norm, especially among younger, college-educated white women. Though a common misconception, the idea that hairless is somehow hygienic isn’t rooted in any real science. “It might feel ‘cleaner’ — but that’s like saying shaving your head bald makes your head cleaner than if you have long, wavy hair,” said Fahimeh Sasan, DO, an assistant professor of obstetrics, gynecology, and reproductive science at the Icahn School of Medicine at Mount Sinai. “As long as you wash yourself every day and change your underwear, you’re going to be just as clean.” - Fahimeh Sasan, DO, Assistant Professor, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai Learn more: http://www.nydailynews.com/life-style/health/hair-american-women-bare-article- 1.2694286

Health – June 20 9 Things Every Woman Must Know About Her Fertility — Hallie Levine A woman’s monthly cycle can offer some clues to her fertility. "If it's longer than 25 to 30 days, that could be a sign you're not ovulating regularly," Fahimeh Sasan, DO, an assistant professor of obstetrics, gynecology, and reproductive science at the Icahn School of Medicine at Mount Sinai. Short menstrual cycles are a red flag as well. - Fahimeh Sasan, DO, Assistant Professor, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai Learn more: http://www.health.com/health/gallery/0,,20987648,00.html#your-period-hints-at-your- fertility-0

Web MD – June 25 Psoriatic Arthritis: 10 Tips to Ease Pain — Barbara Brody Psoriatic arthritis can be a challenge to manage, but some lifestyle changes can help. “Inflammation has been linked to increased pain; your diet may help, said Houman Danesh, MD, the director of integrative pain management at The Mount Sinai Hospital. “Avoid processed foods and focus on berries, turmeric, garlic, vegetables, salmon, black cod, and sardines.” - Houman Danesh, MD, Assistant Professor, Anesthesiology, Rehabilitative Medicine, Icahn School of Medicine, Director, Division of Integrative Pain Management, The Mount Sinai Hospital Learn more: No web links available.

If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200